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Protein aggregation is a common pathologic feature of various 
neurodegenerative disorders including polyglutamine (polyQ) diseases. 
Disease-associated proteins that contain an expanded polyQ tract show a tendency to 
form aggregates and trigger neuronal dysfunction in polyQ-induced degeneration. 
Expanded polyQ proteins exist in various biophysical conformations that display 
different biochemical solubility properties. However, it remains unclear which forms 
of the expanded polyQ protein species cause neurodegeneration. In the present study, 
an inducible transgenic Drosophila model was established, and used to study the role 
of polyQ protein aggregates in neurodegeneration in vivo. Induction of expanded 
polyQ protein expression caused progressive degeneration of neurons in this model 
organism. Changes in levels of microscopically visible polyQ protein aggregates 
were not correlated with either pathogenic or protective effects on neuronal 
degeneration. However, biochemical analysis identified a distinct toxic fraction of 
expanded polyQ protein, which is sodium-dodecyl sulfate (SDS) insoluble and of 
size less than 220 nm. Atomic force microscopic analysis further defined such toxic 
expanded polyQ protein fraction to contain spherical oligomers with sizes of 5 to 20 
nm. Collectively, this study provides in vivo evidence for the existence of spherical 
i 
polyQ oligomers that implicate neurotoxicity. 
ii 
ABSTRACT (CHINESE VERSION) 
蛋白聚集是多聚谷氣酰胺病（polyglutamine diseases; polyQ diseases)等多 
種神經退化性疾病的共同病理特徵。導致多聚谷氣酰胺病的蛋白帶有一段過度 
擴增的多聚谷氨酰胺序列，這類蛋白傾向形成蛋白聚集體(aggregates) ’並引起 
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1.1 Neurodegenerative disorders 一 a brief overview 
Neurodegenerative disorders are neurological diseases that are often 
characterized by accumulation of microscopically visible protein aggregates in 
neurons (reviewed by Ross and Poirier, 2004) and progressive malfunctioning and/or 
death of neurons (reviewed by Bredesen et al., 2006; Palop et al., 2006). Common 
examples include Alzheimer's disease, Parkinson's disease, amyotrophic lateral 
sclerosis, and various types of unstable triplet repeat expansion diseases (reviewed 
by Gatchel and Zoghbi, 2005; Hardy and Gwinn-Hardy，1998). Despite the peculiar 
characteristics of each pathologic condition, neurodegenerative disorders are often 
diagnosed by loss of memory and mobility in patients (reviewed by Palop et al., 
2006). Since these disease symptoms cannot be clinically recognized until substantial 
deterioration of neuronal function has occurred, pre-symptomatic neuronal 
dysfunction exists (reviewed by Rubinsztein, 2006). Potential mechanisms of 
neuronal dysfunction include dysregulation of neuronal excitation (reviewed by 
Doble, 1999)，malfunctioning of mitochondria (reviewed by Lin and Beal, 2006) and 
impairment of intracellular protein degradation machineries (reviewed by 
Rubinsztein, 2006). 
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1.2 Polyglutamine diseases 
Polyglutamine (PolyQ) diseases are neurodegenerative disorders caused by 
unstable triplet repeat expansion in the genome which results in an expansion of the 
existing glutamine-coding triplet (CAG) repeats in the coding region of affected 
genes (reviewed by Zoghbi and Orr, 2000). At least nine polyQ diseases have been 
identified thus far, and they are Huntington's disease (HD), spinobulbar muscular 
atrophy (SBMA), dentatorubropallidoluysian atrophy (DRPLA) and several types of 
spinocerebellar ataxia (SCA) including SCA 1, 2, 3, 6, 7 and 17 (reviewed by 
Gatchel and Zoghbi, 2005). The CAG repeat expansion results in the production of 
an expanded polyQ tract in the respective disease protein (Table 1). Disease protein 
with an expanded polyQ tract shows a tendency to form microscopically visible 
aggregates in neurons (Figure 1; reviewed by Ross and Poirier, 2004). 
Similar to most other neurodegenerative disorders, polyQ diseases usually strike 
in midlife, trigger progressive neuronal dysfunction, and eventually lead to cognitive 
impairment, motor deficits, as well as neuronal cell loss (reviewed by Zoghbi and 
Orr, 2000). An interesting trait of polyQ diseases is that the size of the glutamine 
repeat expansion is correlated with lower age of onset and the severity of the disease 
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Figure 1. Presence of microscopically visible aggregates in 
brain tissues of patients with polyglutamine disease. A 
hallmark feature of polyglutamine diseases is the formation of 
microscopically visible disease protein aggregates in affected 
neurons. The image shown is the occurrence of nuclei-containing 
disease protein aggregates (indicated by arrow) in a brain tissue 
section of a patient with spinocerebellar ataxia type 3. (Adapted 
from Paulson et al. (1997)). 
4 
number for pathogenesis is around 40 (Table 1). 
Most polyQ diseases show a dominant pattern of inheritance (reviewed by 
Zoghbi and Orr, 2000). It has been suggested that the glutamine repeat expansion 
would cause a loss-of-function of the wild type disease protein in which its activity 
can be reduced up to 50 percent (reviewed by Cattaneo et al., 2001). However, polyQ 
diseases are not caused by a simple loss-of-function mechanism (reviewed by 
Rubinsztein, 2006). In fact, expanded polyQ protein also provokes a common toxic 
gain-of-function mechanism which has significant implications on disease 
pathogenesis (reviewed by Di Prospero and Fischbeck, 2005). Toxicity conferred by 
the glutamine repeat expansion is directly supported by that comparable disease 
phenotypes occur, even if the expanded polyQ tract is carried by unrelated cellular 
proteins such as hypoxanthine phosphoribosyltransferase (Ordway et al., 1997) and 
enhanced green fluorescent protein (EGFP; Lam and Chan, unpublished data), or is 
expressed without any adjoining sequence (Adachi et al., 2001; Lievens et al., 2005; 
Marsh et al” 2000). A toxic gain-of-function mechanism could potentially be 
mediated through the aberrant interaction between the expanded polyQ protein and 
various cellular factors (see below, section 1.3). 
5 
It is well documented that expanded polyQ proteins interfere with the gene 
transcription (reviewed by Butler and Bates, 2006; Riley and Orr, 2006), protein 
folding (reviewed by Brignull et al , 2007; Huen et al.，2007), and protein 
degradation (reviewed by Rubinsztein, 2006) machineries. For example, a number of 
cAMP-response-element Binding Protein (CBP)-dependent transcriptional activities 
(Jiang et al., 2006; McCampbell et al., 2000; Nucifora et al., 2001; Wyttenbach et al., 
2001), the level of various molecular chaperones (Chang et al., 2005; Hay et al., 
2004; Huen and Chan, 2005; Tsai et al., 2005; Wen et al, 2003) and the activity of 
the ubiquitin-proteasome system (Bence et al., 2001; Bennett et al., 2005) are 
depleted in polyQ pathogenesis. Such interference provides the basis for neuronal 
dysfunction to occur (reviewed by Brignull et al., 2007; Butler and Bates, 2006; 
Gatchel and Zoghbi, 2005; Rubinsztein, 2006). This is further supported by that 
over-expression of transcription regulators like CBP (Jiang et al., 2006; McCampbell 
et al., 2000; Nucifora et al., 2001; Taylor et al., 2003b) and molecular chaperones 
(Chan et al” 2000; Cummings et al., 2001; Fernandez-Funez et al., 2000; 
Kazemi-Esfarjani and Benzer, 2000; Kobayashi et al., 2000; Warrick et al., 1999) 
suppresses polyQ-mediated toxicity. Puzzlingly, while most disease proteins are 
widely expressed throughout the brain and other tissues, only subsets of neurons are 
susceptible to dysfunction (Table 1). Up till now, the mechanisms by which neuronal 
6 
dysfunction instigated in particular cell types remain unclear (reviewed by Michalik 
and Van Broeckhoven, 2003). 
1.3 Microscopically visible polyglutamine protein aggregates and 
its relation to toxicity 
Neurodegenerative disorders including polyQ diseases are frequently 
characterized by accumulation of microscopically visible protein aggregates in 
affected neurons (Figure 1; reviewed by Ross and Poirier, 2004). The involvement of 
these protein aggregates in polyQ pathogenesis has been extensively studied for over 
a decade (reviewed by Michalik and Van Broeckhoven, 2003; Ross and Poirier, 2005; 
Slow et al.，2006). 
To resolve the role of microscopically visible polyQ protein aggregates, some 
researchers have attempted to ascertain their composition. These aggregates are not 
solely composed of the respective expanded polyQ disease protein; a range of 
cellular factors are also present in them (reviewed by Michalik and Van Broeckhoven, 
2003). Sequestration of cellular factors to polyQ aggregates has been speculated to 
compromise their normal activities and eventually lead to neuronal dysfunction. For 
example, various transcription regulators, including CBP (McCampbell et al,, 2000; 
7 
Steffan et al., 2000), localize to microscopically visible polyQ aggregates. 
Recruitment of CBP to these aggregates may account for the down-regulation of a 
number of CBP-dependent transcriptional activities observed in polyQ pathogenesis 
(Jiang et al., 2006; McCampbell et al., 2000; Nucifora et al., 2001; Wyttenbach et al., 
2001). Other cellular proteins include molecular chaperones, ubiquitin and 
proteasome subunits have also been identified in these polyQ aggregates (Chai et al., 
2001; Doi et al., 2004; Jana et al., 2001; Mitsui et al., 2002; Stenoien et al., 1999; 
Suhr et al., 2001; Warrick et al., 1999). Molecular chaperones assist proper folding of 
proteins as well as their degradation when the proteins cannot be folded properly 
(reviewed by Bukau et al., 2006; Young et al., 2004)，whereas ubiquitin and 
proteasome subunits are involved in the degradation and clearance of misfolded 
proteins (reviewed by Rubinsztein, 2006). Co-aggregation of these cellular factors 
with polyQ aggregates has been proposed to limit cellular protein folding and 
degradation machineries, which in turn lead to accumulation of misfolded and 
damaged proteins. 
Recruitment of cellular proteins to microscopically visible polyQ aggregates 
does not necessarily mean that they are irreversibly trapped. Indeed, some studies 
have revealed that certain recruited proteins including CBP (Stenoien et al., 2002), 
8 
molecular chaperone Heat shock protein 70 (Hsp70; Kim et al., 2002) and 
proteasome subunits (Stenoien et al., 2002) were only transiently associated with 
these aggregates. It has also been demonstrated that transcription factors including 
CBP are not depleted by polyQ aggregates (Yu et al., 2002). Whether or not the 
recruitment of cellular proteins into poIyQ aggregates will bring about neuronal 
toxicity remains disputed. 
Cell death has been reported to occur devoid of microscopically visible 
aggregates (Schiffer et al., 2007). Formation of microscopically visible polyQ 
aggregates is correlated with reduced cell death in cultured neurons (Arrasate et al., 
2004). It is plausible to speculate that the recruitment of molecular chaperones and 
components of the ubiquitin-proteasome system into these aggregates is indeed a 
cellular defensive mechanism to assist proper folding and degradation of the 
expanded polyQ protein, and that aggregate formation prevents the toxic polyQ 
protein species from forming aberrant interactions with other cellular proteins 
(reviewed by Michalik and Van Broeckhoven, 2003; Ross and Poirier, 2005; Slow et 
al., 2006). It is yet to confirm the protective role of microscopically visible protein 
aggregates in polyQ pathogenesis. 
9 
The link between protein aggregation and polyQ pathogenesis has long been 
recognized, but a causal relationship has not been unequivocally established. One 
concern is that polyQ protein aggregates develop progressively with time, and so 
they have been speculated to have multiple roles during disease progression (Morton 
et al., 2000). In addition, the composition of microscopically visible polyQ 
aggregates varies considerably among different cell types (Wanderer and Morton, 
2007), from cell to cell of the same type (Wanderer and Morton, 2007) and even 
within an individual cell at different times (Takahashi et al., 2002; Wanderer and 
Morton, 2007). The role of protein aggregates in polyQ pathogenesis still awaits 
further examination. 
1.4 Polyglutamine protein conformers and their relation to toxicity 
Expanded polyQ protein has been proposed to form stable p-sheet-rich 
structures, through intra- and inter-molecular hydrogen bonds (Perutz et al., 1994). 
Multiple biophysical conformations have been reported for the expanded polyQ 
protein, which include monomers (Nagai et al” 2007)，spherical oligomers 
(Ehrnhoefer et al., 2006; Mukai et al., 2005; Wacker et al., 2004), annular oligomers 
(Wacker et al., 2004), amorphous aggregates (Muchowski et al., 2000; Wacker et al., 
2004), protofibrils (Diaz-Hernandez et al., 2004; Li et al., 2006; Poirier et al., 2002) 
1 0 
and fibrils (Dahlgren et al.’ 2005; Muchowski et al., 2000; Poirier et al., 2002; 
Scherzinger et al., 1999; Wacker et al., 2004). Temporal analyses have demonstrated 
a sequential occurrence of spherical oligomers, protofibrils and fibrils (Figure 2; 
Poirier et al., 2002; Wacker et al., 2004). When the fibrils are large enough, they 
become microscopically visible (reviewed by Ross and Poirier, 2005). Possible 
pathways for the formation of these polyQ conformers are illustrated in Figure 3，in 
which the aggregation process is initiated by a p-sheet conformational transition of 
the expanded polyQ protein monomer from its native state (Nagai et al., 2007). The 
exact mechanisms by which these polyQ protein conformers form are however 
uncertain. 
Disease proteins with stable p-sheet-rich structures are generally believed to 
trigger cellular toxicity in various neurodegenerative disorders (reviewed by Frid et 
al., 2007; Ross and Poirier, 2004). Expanded polyQ protein species in form of 
monomers of p-sheet conformation (Nagai et al., 2007), spherical oligomers 
(Ehrnhoefer et al., 2006) and protofibrils (Diaz-Hernandez et al, 2004; Li et al., 2006) 
have been proposed to associate with toxicity in several polyQ disease models. First, 
expanded polyQ protein monomers of (3-sheet conformation initiated cytotoxicity 
when injected into cultured cells (Nagai et al., 2007). Second, treatment of cells with 
1 1 
mm 
觀:• _ _ 
Figure 2. Sequential occurrence of polyglutamine oligomers, 
protofibrils and fibrils. Time course of polyglutamine disease 
protein aggregation in vitro monitored under transmission 
e lect ron microscopy. Spherical o l igomers ( indicated by 
arrowheads) were observed at 2 and 3 hr after the enzymatic 
initiation of the aggregation process. Spherical oligomers 
(indicated by arrowheads) and protofibrils (indicated by arrows) 
co-existed from 4 to 6 hr. By 7 and 8 hr, only fibrils (indicated 
by arrows) were detected. The fibrils were seen bundled 
together. Scale bar represents 200 nm. (Adapted from Poirier et 
al. (2002)). 
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Figure 3. A schematic diagram of the proposed model of 
polyglutamine protein aggregation pathways. Expanded 
polyglutamine disease protein exists in several conformations. 
The expanded polyglutamine protein monomers adopt abnormal 
conformations and initiate the aggregation process. Fibrils are 
formed by addition of monomers to the growing fiber, or 
through intermediate species such as oligomers and protofibrils, 
of which trigger the formation of annular ring structures 
(annular oligomers) and amorphous aggregates. When fibrils or 
amorphous aggregates become large enough, they can be 
visualized under light microscopy. These microscopically 
visible aggregates are also termed inclusion bodies. (Adapted 
from Ross and Poirier (2005)). 
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chemical compounds like green tea polyphenol (-)-epigallocatechin-3-gallate was 
shown to suppress polyQ-mediated toxicity and modulate spherical oligomer 
formation (Ehrnhoefer et al., 2006). Further, both castration (Li et al” 2006) and 
reduction of polyQ transgene expression (Diaz-Hernandez et al., 2004) in mice 
prevented neurodegeneration and eliminated the accumulation of protofibrils. 
However, the mechanism by which these polyQ conformers cause toxicity remains 
unaddressed. It is yet too preliminary to have any concrete conclusion on the distinct 
biophysical conformation of polyQ protein species that underlie neurodegeneration. 
1.5 Modeling polyglutamine diseases in Drosophila 
1.5.1 GAL4/UAS spatial transgene expression system in Drosophila 
Many human diseases are tissue-specific in nature so that regional expression of 
transgene would better mimic the pathologic conditions in patients. A bipartite 
spatial transgene expression system can therefore be used to restrict the expression of 
a transgene in particular Drosophila cell types (Figure 4; Brand and Perrimon, 1993). 
Two kinds of transgenic flies must first be generated: one line carries a cell 
type-specific promoter/enhancer sequence fused upstream to the yeast transcriptional 
activator GAL4 gene (driver line), and a second line carries the transgene which is 







































































































































































































(target line). In the progeny of the driver and target lines, the yeast GAL4 
transactivator would be expressed in cells which the endogenous promoter/enhancer 
sequence are active. Since the transgene is located downstream of the GAL4 binding 
sequence (UAS), expression of UAS-transgene would then be detected. For example, 
multiple copies of the glass gene promoter sequence have been placed upstream of 
the yeast GAL4 gene, and this glass multiple reporter {gmr)-GALA line can be used 
to direct expression of UAS-transgene in all eye cells posterior to the morphogenetic 
furrow, including photoreceptor neurons and eye pigment cells (Ellis et al., 1993). 
The driver and target lines are carried in different parental transgenic fly strains. This 
ensures the viability of the parental fly strains especially when cytotoxic proteins are 
studied, and also enables the use of the same target line to study the effect of the 
transgene in different tissues simply by performing genetic crosses with different 
driver lines. 
1.5.2 Temporal control of GAL4/UAS transgene expression system in Drosophila 
The GAL4/UAS system controls only the spatial expression pattern of the gene 
of interest (section 1.5.1). One limitation of the GAL4/UAS system is the lack of 
temporal regulation over the transgene expression. Additional approaches have been 
developed over the conventional GAL4/UAS system to tackle this issue in 
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Drosophila. They include the Gene-Switch system (Han et al., 2000; Osterwalder et 
al., 2001; Roman et al., 2001) and the temporal and regional gene expression 
targeting (TARGET) system (McGuire et al., 2003). 
In the Gene-Switch system (Figure 5A)，fly strain with a promoter/enhancer 
sequence located upstream of a G^Z^-hormonal receptor fusion gene is constructed 
as the driver line. In the absence of hormone, the GAL4-containing fusion protein is 
expressed but adopts an inactive conformation such that it cannot bind to UAS to 
trigger transcriptional activation. Upon hormonal exposure, the fusion protein 
converts into an active conformation, binds to UAS, and activates transgene 
expression. Induction of transgene expression is therefore determined by the 
hormonal exposure on flies. 
Another approach to aid temporal transgene expression is the TARGET system 
(Figure 5B). In yeast, the GAL4-mediated transcriptional activation can be repressed 
by the GAL80 protein (reviewed by Lohr et al., 1995). The GAL80 protein can also 
repress the GAL4/UAS-mediated transgene expression in Drosophila (Lee and Liio, 
1999). McGuire et al. (2003) further established a temperature-sensitive GAL80 
























































































































































































































































































































































































































































































































































































































































































in Drosophila, which grounds the basis of the TARGET system. Fly strain with a 
tubulin promoter sequence placed upstream of a GAL8(f gene is constructed as an 
additional driver line to aid ubiquitous expression of GAL80^ ® protein. When flies 
with the GAL80ts driver are crossed to flies bearing both the GAL4 driver and 
UAS-transgene, at a permissive temperature for the action of GAL80^^ (i.e. under 
19°C), the GALSQts protein binds to the transcriptional activation domain of the 
GAL4 protein and prevent the GAL4-mediated transcriptional activation. At a 
non-permissive temperature for the action of GALSO^ GAL80^ ® adopts an inactive 
conformation and the GAL80-mediated transcriptional repression is thus relieved. In 
this way, induction of transgene expression can be controlled by raising flies at 
desired temperature. 
1.5.3 Drosophila as a model to study human pathologies 
For a number of reasons that the fruit fly Drosophila melanogaster emerges as 
one of the most popular model organisms to study various biological mechanisms 
(reviewed by Arbouzova and Zeidler, 2006; Casanova, 2007; Sanchez-Soriano et al., 
2007; Wager-Smith and Kay, 2000). Most importantly, flies have a relatively short 
life cycle (Figure 6; about 10 days at 25�C), and that a large number of progeny can 
be produced to enable large-scale analysis. Their anatomy and physiology are also 
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extensively studied to facilitate phenotypic examination. All these, together with 
well-developed transgene expression systems (section 1.5.1; section 1.5.2) and the 
genome-wide collection of transgenic fly stocks (reviewed by Ryder and Russell, 
2003; Venken and Bellen, 2005) allow rapid in vivo analysis of gene functions. 
Furthermore, comparison between the Drosophila and human genomes revealed a 
high degree of conservation in fundamental biological pathways (Rubin et al., 2000), 
and that over 60 percent of human disease genes have orthologs in flies (Reiter et al., 
2001). This makes Drosophila a suitable organism to study human disease-related 
biological mechanisms. Overall, these features have made Drosophila an attractive 
model for studies of human diseases (reviewed by Bier and Bodmer, 2004; Bilen and 
Bonini, 2005; Garesse and Kaguni, 2005; Marsh and Thompson, 2006; O'Kane, 2003; 
Sang and Jackson, 2005; Vidal and Cagan, 2006). 
1.5.4 Drosophila as a model to study polyglutamine diseases 
Drosophila has a complex nervous system with an architecture similar to that of 
the mammalian nervous system (reviewed by Yoshihara et al., 2001), and has been 
used to study various neurodegenerative disorders including polyQ diseases 
(reviewed by Bilen and Bonini, 2005; Marsh and Thompson, 2006; Sang and 
Jackson, 2005; Shulman et al., 2003). The polyQ disease was initially modeled in 
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Drosophila by over-expression of a truncated form of human SCA 3, also known as 
Machado-Joseph disease (MJD), disease protein using the conventional GAL4/UAS 
spatial transgene expression system (Warrick et al., 1998). Directed expression of the 
truncated form of expanded MJD protein with 78 glutamine repeats (MJDtrQ78) in 
all neurons in Drosophila led to premature death (Warrick et al., 1998). Constitutive 
expression of MJDtrQ78, but not the truncated form of unexpanded MJD protein 
with 27 glutamine repeats (MJDtrQ27), in the fly eye under the control of 
gmr-GALA caused late-onset progressive degenerative phenotypes such as 
depigmentation and collapse of internal retinal morphology (Figure 7A, C; Warrick 
et al., 1998). Besides, the pathogenic expanded MJDtrQ78 protein was found to 
accumulate in form of microscopically visible protein aggregates (Figure 7B; 
Warrick et al., 1998). Both the severity of degenerative phenotypes and the onset of 
microscopically visible protein aggregates mediated by the expanded MJD protein 
were shown to correlate well with both the expression level and the glutamine repeat 
length of the protein (reviewed by Bilen and Bonini, 2005). 
Drosophila models of other polyQ diseases have also been successfully 
established by the over-expression of respective human poIyQ disease proteins. They 
include huntingtin protein for HD (Jackson et al., 1998), androgen receptor protein 
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Figure 7. Constitutive expression of the MJD protein in 
Drosophila, (A) Observation of the adult external fly eye. 
Constitutive expression of MJDtrQ78, but not MJDtrQ27 and 
MJDtrQ61, caused eye depigmentation at 2 to 3 days post-eclosion 
(dpe). (B) Immunofluorescence analysis of the adult fly retina. 
Constitutive expression of MJDtrQ61 and MJDtrQ78 resulted in the 
formation of polyQ aggregates (shown in green) at 2 to 3 dpe. (C) 
Monitoring of adult fly retinal morphology under fluorescence 
microscopy. Constitutive expression of MJDtrQ78, but not 
MJDtrQ27 and MJDtrQ61, led to a reduction in the depth of the 
retina (indicated by double-headed arrows) at 2 to 3 dpe. DAPI was 
used to stain the cell nuclei (shown in red). This method has been 
commonly used to assess retinal cell death (Boeddrich et al. (2006); 
Femandez-Funez et al. (2000); Warrick et al. (2005)). Scale bars 




Figure 7 (continued). (D) Immunofluorescence analysis 
of the larval imaginal eye disc. Constitutive expression 
of MJDtrQ78 led to the formation of polyQ aggregates 
(shown in green). DAPI was used to label the cell nuclei 
(shown in red). In this constitutive expression system, 
gmv-GAhA drives UAS-transgene ( i .e . UAS-
MJDtrQ78(s)) expression in all cells posterior to the 
morphogenetic furrow in the larval imaginal eye disc 
(Ellis et al. (1993)) and a new row of eye disc cells 
would start to express UAS-transgene in roughly every 2 
hr. Ten eye discs were examined to determine cell rows 
with polyQ aggregates (right panel; indicated by double-
headed arrows) and polyQ aggregates (shown in green) 
were found to appear from about 8 rows of cells from 
the furrow (indicated by arrows). Scale bars represent 50 
fim. The larva and flies were of genotypes w; gmr-
GAL4 UAS-MJDtrQ27/+', +/+，m；; gmr-GAL4 UAS-
MJDtrQ61/+\ + / + and w; gmr-GAL4 UAS-
MJDtrQ78(s)l+', +/+. 
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for SBMA (Chan et al., 2002; Takeyama et al., 2002)，atrophin-1 protein for DRPLA 
(Charroux et al., 2006), ataxin-1 protein for SCA 1 (Fernandez-Funez et al , 2000) 
and ataxin-7 protein for SCA 7 (Latouche et al., 2007). The various Drosophila 
models of polyQ diseases have provided primary insights to link a range of cellular 
pathways to poIyQ-mediated neuronal dysfunction. Examples include protein folding 
(Warrick et al., 1999), transcriptional regulatory (Steffan et al., 2001), cell signaling 
(Chen et al., 2003), apoptotic (Sang et al., 2005) and microRNA regulatory (Bilen et 
al., 2006) pathways. Drosophila emerges as a valuable model organism to find out 
biological pathways that underlie polyQ-mediated neurodegeneration. 
To conclude, transgenic polyQ disease fly models exhibit disease characteristics 
that resemble pathologic conditions observed in patients (reviewed by Bilen and 
Bonini，2005; Marsh and Thompson, 2006); Drosophila would therefore be a useful 
model to elucidate pathogenic mechanisms in polyQ diseases in vivo. 
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1.6 Aims of study 
Aggregation of disease protein is a feature shared among neurodegenerative 
disorders including polyQ diseases (reviewed by Ross and Poirier, 2004). Over the 
last decade, the involvement of polyQ disease protein aggregation in neuronal 
degeneration has been a central area of research (reviewed by Michalik and Van 
Broeckhoven, 2003; Ross and Poirier, 2005; Slow et al., 2006). Disease protein with 
an expanded polyQ tract exists in multiple aggregated forms such as oligomers, 
protofibrils and fibrils (reviewed by Ross and Poirier, 2005); the pathogenic form of 
the expanded polyQ protein remains yet to be explicitly defined and characterized. 
This project aims to reveal the relationship between polyQ disease protein 
aggregation and neurodegeneration, and with the intention to uncover the pathogenic 
form of polyQ protein species that cause neurodegeneration. The experimental model 
used in this study is Drosophila, a model organism that allows rigorous examination 
on the pathogenic mechanisms of polyQ disease in vivo. 
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2. MATERIALS AND METHODS 
2.1 Drosophila culture and manipulation 
2.1.1 Drosophila culture 
Fly stocks and crosses were raised in cotton-plugged plastic vials containing 
cornmeal-yeast-glucose-agar medium (section 2.10.1) in temperature-controlled 
incubators (LMS). All genetic crosses were maintained at either 18�C or 25°C. For 
each cross, around 4 male and 6 female virgin flies were put together in a fly vial 
supplemented with dry yeast. For collection of virgin females, adult flies were first 
removed from the vial, and virgin female flies were collected in the following 8 hr at 
25°C or 16hrat IS'^ C. 
2.1.2 Phenotypic examination of adult external eye degeneration 
Adult fly eyes of appropriate genotype and age were examined under a 
stereomicroscope (Olympus SZE-12). External eye images were captured by a SPOT 
Insight CCD camera (Diagnostic Instruments Inc.) using SPOT Advanced software 
(version 4.1; Diagnostic Instruments Inc.). The images were optimized for their 
brightness and contrast on Adobe Photoshop 7.0 (Adobe) and such manipulations 
were applied across the entire image. 
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2.1.3 Pseudopupil assay of adult retinal degeneration and observation of green 
fluorescent protein in adult eyes 
Adult fly heads of appropriate genotype and age were decapitated, put on a 
glass slide, and immersed in a drop of immersion oil (Olympus). Around 5 fly heads 
were aligned in a straight line on each glass slide in an orientation that antennae were 
facing upward and ocelli were facing forward. With two glass cover slips served as 
spacers on both sides, a third glass cover slip was carefully placed on top of the fly 
heads. The glass cover slip junction was then sealed with nail polish. Ommatidia 
were examined under a light microscope (Olympus CX31) using a 60X oil objective 
with numerical aperture (NA) of 1.25. To visualize ommatidia and green fluorescent 
protein (GFP) signals simultaneously in the fly eye, a fluorescence microscope 
(Olympus BX51) equipped with a 60X/ NA 1.4 oil objective was used. Ommatidial 
images were captured by a SPOT Insight CCD camera (Diagnostic Instruments Inc.) 
using SPOT Advanced software (version 4.1; Diagnostic Instruments Inc.). The 
images were optimized for their brightness and contrast on Adobe Photoshop 7.0 
(Adobe) and such manipulations were applied across the entire image. 
The ommatidia integrity was revealed by the number of rhabdomeres per 
ommatidium. In each experiment, at least 100 ommatidia were counted at random 
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from 5 to 10 fly eyes, and the average number of rhabdomeres per ommatidium 
count was determined. Each experiment was repeated independently for three times. 
For pseudopupil analysis along with GFP signal detection, at least 80 ommatidia 
were randomly counted from 8 fly eyes. Two independent experiments were 
performed. Sample mean value and standard error of the mean {s.e.m.) were 
calculated to determine the variation among individual flies. Mean differences of 
average numbers of rhabdomeres per ommatidium count between samples were 
compared by Mann-Whitney U-test (SPSS 12.0 for Windows). Statistical 
significance was demonstrated by p-value of less than 0.05. 
The Image Pro Plus imaging software (version 5.1; Media Cybernetics) was 
used to determine the area occupied by GFP-positive polyQ aggregates in an 
ommatidium. For each of the 80 ommatidia, the area of GFP signals was measured. 
The area occupied by the GFP-positive polyQ aggregates in each ommatidium was 
calculated by dividing the total area of GFP signals by the overall area of a single 
ommatidium. 
Linear regression (SPSS 12.0 for Windows) was performed to determine the 
correlation between the area occupied by GFP-positive polyQ aggregates and the 
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average number of rhabdomeres per ommatidium count. 
2.2 Semi-quantitative Reverse Transcription-Polymerase Chain 
Reaction 
2.2.1 RNA extraction from adult Drosophila heads 
Ribonucleic acid (RNA) was extracted from adult fly heads using TRIZOL 
reagent (Invitrogen). Sixteen fly heads were homogenized in 800 |xl of TRIZOL 
reagent with a motorized plastic pestle (Kontes). Homogenates were first centrifuged 
at 12,000 X g for 10 min at 4 � C to remove cell debris. Supernatant was then 
transferred to a fresh tube and incubated for 5 min at room temperature. A volume of 
160 of chloroform was added to the supernatant and incubated for another 2 min at 
room temperature. The sample mixture was centrifuged at 12,000 X g for 15 min at 
4°C. The aqueous upper phase was collected in a fresh tube, and 400 \i\ of 
isopropanol was added to precipitate the RNA overnight at -20°C. The sample was 
centrifuged at 12,000 X g for 10 min at 4°C, and the supernatant was discarded. The 
resultant RNA pellet was washed with 1 ml of 70% ethanol, and centrifuged again at 
12,000 X g for 10 min at 4°C. Ethanol was then removed; the pellet was air-dried at 
room temperature and dissolved in 50 |il of diethyl pyrocarbonate (DEPC)-treated 
water (section 2.10.2). 
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2.2.2 DNase treatment of extracted RNA 
Ribonuclease (RNase)-free deoxyribonuclease (DNase; Promega) was used to 
digest the residual deoxyribonucleic acid (DNA) left in the extracted RNA. A 
reaction mixture of 50 |li1 of total RNA, 6 \i[ of lOX DNase buffer (Promega), 3 p-l of 
DNase (1 U / | L I 1 ; Promega) and 1 \i\ of DEPC-treated water was first prepared, and 
then incubated for 15 min at room temperature. To terminate the reaction, 6 |il of 
DNase stop solution (Promega) was added to the reaction mixture and incubated for 
10 min at 65°C. To precipitate the RNA, 8 |il of sodium acetate and 6 fxl of 
DEPC-treated water were added to the reaction mixture followed by the addition of 
160 of 100% ethanol. The RNA was precipitated overnight at -80°C. The sample 
mixture was centrifuged at 12,000 X g for 15 min at 4°C. The pellet was washed in 1 
ml of 70% ethanol, and the sample was centrifuged again at 12,000 X g for 10 min at 
4°C. Ethanol was then removed; the pellet was air-dried at room temperature and 
dissolved in 50 of DEPC-treated water. 
2.2.3 Reverse Traiiscriptioii-Polymerase Chain Reaction (RT-PCR) 
Reverse transcription (RT) was performed using oligo(dT) primer (10 ).iM; 
section 2.10.2). A mixture of 4 \i\ of total RNA and 1 …of oligo(dT) primer was first 
incubated at 70�C for 5 min to completely denature the RNA, and then chilled at 4"C 
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for 5 min. A volume of 4 of 5X reaction buffer (Promega), 2.4 |xl of 25 mM 
Magnesium Chloride (MgCb; Promega), 0.5 i^l of 20 mM deoxynucleoside 
triphosphates (dNTPs) mixture (Promega), 0.5 [i\ of RNase inhibitor (40 U/|il; 
Promega), 1 of reverse transcriptase (Promega) and 6 |li1 of DEPC-treated water 
were then added to the reaction mixture. The RT reaction was performed as follows: 
5 min at 25°C, 60 min at 42°C, and 15 min at 70°C. 
PGR amplification from the synthesized first strand complementary DNA 
(cDNA) was then performed in a reaction mixture containing 1.5 )LI1 of the cDNA 
template, 2.5 |li1 of lOX PGR reaction buffer, 1.5 of 25 mM MgCb (Promega), 0.3 
of 20 mM dNTPs (Promega), 0.5 \.i\ of 10 J L I M forward primer, 0.5 |LII of 10 | I M 
reverse primer, 0.2 |il of Thermus aquaticus (Tag) DNA polymerase (GeneSys 
Limited) and 18 [il of autoclaved double distilled water. PGR conditions were as 
follows: 30 sec at 95°C, 30 sec at 60�C，and 45 sec at 71�C for 30 cycles. Primers 
used were (ExprFl) 5，CGG A AG AG A CGA GAA GC 3'; (ExprR) 5' GTG A AG 
GTA GCG AAC ATG 3，for MJDtrQ78\ (ActinF) 5，ATG TGC AAG GCC GGT TTC 
GC 3，and (ActinR) 5，CGA CAC GCA GCT CAT TGT AG 3’ for actin. Both RT and 
PGR reactions were performed on an i-Cycler thermocycler (Bio-Rad Laboratories). 
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2.2.4 Agarose gel electrophoresis 
Electrophoresis was carried out in wide-mini-sub cell GT system (Bio-Rad 
Laboratories). DNA sample was mixed with 6X DNA loading dye (section 2.10.2) in 
volume ratio of 5:1, and run on a 1% agarose gel (w/v; section 2.10.2) in IX 
Tris-Borate-EDTA (TBE) buffer (section 2.10.2) at 120 V until the dye front reached 
two-third of the gel or at an appropriate position. For each agarose gel, 2 |il/lane of 
DNA ladder (section 2.10.2) was loaded as molecular weight markers. 
DNA band intensities were measured using AlphaEaseFC software (version 
3.1.2; Alpha Innotech Corporation). Sample mean value and s.e.m. were calculated 
from three independent experiments. Differences in sample means were compared by 
two-tailed, unpaired Student's t-test (Microsoft Office Excel 2003). Statistical 
significance was demonstrated by p-value of less than 0.05. 
2.3 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
2.3.1 Protein extraction from adult Drosophila heads 
Fifteen adult fly heads were homogenized in 75 |li1 of ice-cold 6X SDS sample 
buffer (section 2.10.3) with a motorized plastic pestle (Kontes). Homogenates were 
3 3 
either left unfiltered or filtered through an Ultrafree-MC membrane (Millipore) with 
pore size of 0.22 |im at 13,400 X g- for 4 min at room temperature. Protein extracts 
were denatured at 99°C for 5 min, and stored at -20°C until use. 
2.3.2 Preparation of SDS-poIyacrylamide gel and electrophoresis 
Electrophoresis was performed using the Mini-PROTEAN III electrophoresis 
cell (Bio-Rad Laboratories). Glass plates with 0.75 mm or 1.5 mm spacers were 
cleaned and vertically assembled into a gel cassette according to manufacturer's 
instructions. Running gel solution was prepared according to section 2.10.3 and 
loaded to the space between assembled glass plates. Isopropanol was then added onto 
the top of the running gel solution to remove any air bubbles and to keep the gel 
solution away from atmospheric oxygen. The running gel solution was allowed to 
polymerize for about 20 min at room temperature or until the gel was set. 
Isopropanol was removed from the running gel surface. The gel surface was rinsed 
with double distilled water and dried. Stacking gel solution was prepared according 
to section 2.10.3 and loaded to the top of the running gel. A gel comb of appropriate 
thickness with either 10 or 15 wells was inserted between the glass plates. Stacking 
gel solution was allowed to polymerize for 20 min at room temperature or until the 
gel was set. The gel cassette was then transferred to the electrophoresis cell. The 
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inner cell chamber was filled with freshly prepared IX SDS electrophoresis buffer 
(section 2.10.3) while the outer cell chamber was filled with fresh or reused IX SDS 
electrophoresis buffer (section 2.10.3). The gel comb was removed, and the wells 
were rinsed with fresh IX SDS electrophoresis buffer (section 2.10.3) to remove any 
unpolymerized gel solution prior to sample loading. Protein extracts without cell 
debris were denatured at 99�C for 5 min, and loaded into the wells. For each gel, 5 
jil/lane of broad-range pre-stained protein standard (Bio-Rad Laboratories) was also 
loaded as molecular weight markers. Electrophoresis was performed at constant 
voltage of 80 V initially, and then adjusted to 120 V after the dye front passed the 
stacking gel. The gel was run until the dye front reached the bottom of the running 
gel or at an appropriate position. 
2.3.3 Western blotting 
After electrophoresis, the gel was removed from the cassette of electrophoresis 
cell, and was first rinsed briefly with double distilled water and then equilibrated in 
IX transfer buffer (section 2.10.3). Western blotting was carried out in Mini 
Trans-Blot electrophoretic transfer cell (Bio-Rad Laboratories). Polyvinylidene 
fluoride (PVDF) membrane (PALL) was first activated by analytical grade methanol 
for 10 sec and then equilibrated in IX transfer buffer. Six pieces of 3-mm filter paper 
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(Whatman) and two fiber pads were also soaked in IX transfer buffer. The transfer 
cassette was set up in the following order: a fiber pad on the cathode side of the 
transfer gel holder cassette (black side of the cassette), followed by a stack of three 
filter papers, the gel piece, the PVDF membrane, another stack of three filter papers 
and a fiber pad. The assembled sandwich was rolled over by a glass tube to expel any 
air bubbles trapped. The cassette was then placed into the buffer tank, together with a 
frozen Bio-Ice cooling unit. The tank was then filled up with IX transfer buffer and 
Western blotting was performed at constant voltage of 80 V for 2 hr. 
2.3.4 Immunodetection 
After Western blotting, the PDVF membrane was removed from the transfer gel 
holder cassette, washed with IX Tris-Buffered Saline (TBS; section 2.10.3) for 5 min 
twice, and then blocked with blocking buffer (section 2.10.3) for 2 hr at room 
temperature with continuous shaking. The blot was then incubated with primary 
antibodies diluted in blocking buffer overnight at 4°C with continuous rolling. The 
blot was washed with continuous shaking for four times in TBS-Tween-20 (TBS-T), 
each for 15 min, and followed by secondary antibody incubation in blocking buffer 
for 2 hr at room temperature with continuous rolling. The blot was again washed four 
times in TBS-T, each for 15 min. Finally, signal detection was performed using 
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Enhanced Chemiluminescent (ECL) Western blotting detection reagents (Amersham). 
A volume of 0.5 ml of ECL reagent 1 and 0.5 ml of ECL reagent 2 were first mixed, 
and then applied onto the blot and incubated for 1 min at room temperature. The blot 
was wrapped with a plastic wrap, and then used to expose an X-ray film (FUJI super 
RX) at desired time intervals. The film was developed by a medical X-ray film 
processor (Kodak). For re-probing, the blot was stripped with 20 ml of Western blot 
stripping buffer (Pierce) for 5 min at room temperature with continuous shaking, 
washed with IX TBS for 5 min twice, and then incubated with another set of primary 
and secondary antibodies as described above. Primary antibodies used were rabbit 
anti-hemagglutinin (HA; 1:250; Zymed), rat anti-fly Hsp70 (1:500; a kind gift of Dr. 
Martin Feder, Department of Organismal Biology & Anatomy, The University of 
Chicago, Chicago) and mouse anti- /? -tubulin E7 (1:2,000; Developmental Studies 
Hybridoma Bank, Iowa City, Iowa, with funding from the NICHD). Secondary 
antibodies used were affinity purified goat anti-rabbit, goat anti-rat and goat 
anti-mouse immunoglobulin G (IgG; H + L) horseradish peroxidase 
(HRP)-conjugate (1:2,000; Chemicon). 
Protein band intensities were measured using AlphaEaseFC software (version 
3.1.2; Alpha Innotech Corporation). Sample mean value and s.e.m. were calculated 
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from three independent experiments. Differences in sample means were compared by 
two-tailed, unpaired Student's t-test (Microsoft Office Excel 2003). Statistical 
significance was demonstrated by p-value of less than 0.05. 
2.4 Immunoprecipitation 
Aliquots of 50 |LI1 EZview red anti-HA affinity gel beads HA-7 (Sigma) was 
used in the immunoprecipitation experiment. The gel beads were first equilibrated in 
750 of lysis buffer (section 2.10.4) for 30 sec at 4�C，and then centrifuged at 8,200 
X g for 30 sec at 4°C. The lysis buffer was carefully removed. This step was repeated 
once, and the beads were then stored on ice prior to use. 
With a motorized plastic pestle (Kontes), 50 fly heads were homogenized in 1 
ml of ice-cold lysis buffer freshly supplemented with 1 mM 
phenylmethanesulphonylfluoride (PMSF) and protease inhibitor cocktail (Sigma). 
Homogenates were centrifuged at 8,200 X g for 10 min at 4 � C to remove cell debris. 
The cleared homogenates were transferred to a tube pre-loaded with 50 |il 
equilibrated EZview red anti-HA affinity gel beads. The sample mixture was 
vortexed briefly, and incubated overnight at 4°C with continuous gentle mixing. The 
sample mixture was then subject to centrifugation at 8,200 X g for 30 sec at 4�C，and 
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supernatant was transferred to a new tube and saved as the "flowthrough" fraction. 
The gel beads were washed with 750 |LII of ice-cold lysis buffer, vortexed briefly, and 
incubated for 5 min at room temperature with continuous gentle mixing. The sample 
was then centrifuged at 8,200 X g for 30 sec, and supernatant was carefully removed. 
The washing step was repeated for two more times. Proteins collected in the 
"flowthrough" fraction were precipitated by 10% trichloroacetic acid (TCA) as 
described in section 2.8. To elute the immunoprecipitated proteins, 50 fxl of 6X SDS 
sample buffer (section 2.10.3) was added to the gel beads. The sample mixture was 
then vortexed briefly, boiled at 99°C for 5 min, centrifuged at 8,200 X g for 30 sec, 
and stored at -20°C until use (sections 2.4.2-2.4.4). 
2.5 Filter retardation assay 
Ten fly heads were homogenized in 200 |xl of ice-cold filter retardation sample 
buffer (section 2.10.5) with a motorized plastic pestle (Kontes). Homogenates were 
heated at 99°C for 5 min, and stored at -20�C until use. Alternatively, homogenates 
were first filtered through an Ultrafree-MC membrane (Millipore) with pore size of 
0.22 i^ m at 13,400 X g for 4 min at room temperature prior to storage 
A cellulose acetate membrane with pore size of 0.22 \im (Sartorius) was 
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inserted into the Slot Blot Manifold blot apparatus (Amersham Pharmacia Biotech 
PR 648) connected to a vacuum pump. Double distilled water, 0.01% SDS solution 
(w/v)，and 2% SDS solution (w/v) were sequentially loaded onto each slot to wet and 
equilibrate the membrane. After heating at 99�C for 5 min, the homogenates without 
cell debris were then loaded onto the slots. Each slot was washed twice with 0.01% 
SDS solution (w/v). The membrane was then removed from the blot apparatus, and 
immunodetection was carried out as described in section 2.4.4. 
2.6 Isolation and solubilization of SDS-insoluble protein 
Fifty fly heads were homogenized in 250 |li1 of ice-cold protein extraction 
sample buffer (section 2.10.6) with a motorized plastic pestle (Kontes). Homogenates 
without cell debris were subject to ultracentrifugation at 100,000 rpm (Beckman 
TLX-120; TLA 120.2 rotor; 434,513 X g) for 1 hr at 4�C. The supernatant was 
discarded and the pellet was solubilized in 80 of 100% formic acid (FA; Sigma) at 
37°C for 30 min. Formic acid was then removed by SpeedVac (Savant) at a low 
drying rate for 1 hr at room temperature, and the pellet was dissolved in 10 jxl of 6X 
SDS sample buffer (section 2.10.3). Hydroxide ions, in form of a volume of 10 )il of 
Tris-Hydrochloric acid (Tris-HCI; pH 8.8), was added to the sample to neutralize any 
residual FA prior to SDS-PAGE analysis (sections 2.4.2-2.4.4). 
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2.7 Sucrose gradient sedimentation 
Two hundred fly heads were homogenized in a liquid nitrogen pre-chilled 
mortar and pestle. A volume of 1 ml of ice-cold sucrose gradient sample buffer 
(section 2.10.7) freshly supplemented with 1 mM PMSF was added to the mortar 
after homogenization. Protein extracts were further homogenized on ice with a 1 ml 
Dounce homogenizer (Wheaton) started with 20 loose strokes, and followed by 50 
tight strokes. Homogenates were then subject to centrifugation at 12,000 X g for 5 
min at 4°C twice to remove any residual cell debris. To generate a stepwise gradient, 
ice-cold sucrose gradient buffer containing 5 different sucrose concentrations (10%, 
20%, 30%, 40% and 50%; 2.1 ml each; section 2.10.5) freshly supplemented with 1 
mM PMSF were loaded in ascending order to the bottom of an ultra-clear centrifuge 
tube (capacity 13.2 ml; Beckman) using a thin capillary tubing connected to a 1 ml 
syringe. The stepwise gradient was equilibrated overnight at 4�C to generate a 
continuous gradient. Homogenates without cell debris were then loaded onto the 10.5 
ml of 10% to 50% continuous sucrose gradient, and centrifuged at 35,000 rpm 
(Beckman XL-IOOK ultracentrifuge; SW41 Ti rotor; 151,263 X g) for 16 hr at 4�C. 
Eleven 1 ml fractions were collected by piercing the centrifuge tube with a 25G fine 
needle (Terumo) attached to a 1 ml syringe. The fraction collected from the top of the 
tube was designated as "fraction 1”. 
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Trichloroacetic acid (TCA; 10%; Sigma) was used to precipitate proteins in 
each fraction. Trichloroacetic acid-precipitated protein samples were centrifuged at 
12,000 X g for 45 min at 4''C. Protein pellet was then washed with 300 |il of ice-cold 
acetone, and centrifuged at 12,000 X g for another 30 min at 4°C. The washing step 
was repeated for two more times. Protein pellet was then dissolved in 20 |LI1 of 6X 
SDS sample buffer (section 2.10.3). To isolate proteins with size less than 0.22 |im, 
protein pellet was dissolved in 50 jxl of 2% SDS solution (w/v), and a volume of 30 
)j.l of protein samples were filtered through an Ultrafree-MC membrane (Millipore) 
with pore size of 0.22 |Lim at 13,400 X g for 4 min at room temperature. A volume of 
20 fxl of 6X SDS sample buffer (section 2.10.3) was subsequently added to 20 i^l of 
the protein sample (either filtered or unfiltered) for SDS-PAGE (sections 2.4.2-2.4.4). 
The protein samples were then boiled at 99�C for 5 min, and stored at -20�C until 
use. 
2.8 Preparation of Drosophila tissues for immunofluorescence 
analysis 
2.8.1 Dissection and immunostaining oiDrosophila larval imaginal eye discs 
Imaginal eye discs of appropriate genotypes were dissected from third-instar 
larvae in IX Phosphate-Buffered Saline (PBS; section 2.10.8)，fixed in 3.7% 
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formaldehyde in IX PBS for 15 min, and washed three times in Phosphate-Buffered 
Saline-Triton X-100 (PBS-T; section 2.10.8), each for 5 min. The dissected eye discs 
were then blocked in Phosphate-Buffered Saline-Goat Serum (PBS-GS; section 
2.10.8) for 1 hr at room temperature, and incubated with rabbit anti-HA primary 
antibody (1:250; Zymed) in PBS-GS overnight at 4�C. The eye discs were then 
washed four times in PBS-GS, each for 5 min, and followed by fluorescein 
isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (H+L) secondary antibody 
(1:250; Zymed) incubation in PBS-GS at room temperature for 2 hr. The eye discs 
were further washed four times in PBS-GS, each for 5 min, and then transferred to a 
glass slide loaded with a volume of 40 |li1 of Prolong Antifade Kit (Molecular Probes) 
reagent. Two cover slips were put on sides as spacers, while a third cover slip was 
placed on top of the eye discs and the junction was sealed with nail polish. The eye 
discs were then examined under a confocal microscope (Leica, TCS) equipped with a 
lOOX/ NA 1.4 oil objective. Images of the imaginal eye discs were acquired using 
Leica confocal software (version 2.5; Leica). The images were optimized for their 
brightness and contrast on Adobe Photoshop 7.0 (Adobe) and such manipulations 
were applied across the entire image. 
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2.8.2 Cryosectioning and immunostaining of adult Drosophila heads 
Decapitated adult fly heads were first equilibrated in a well of glass dissection 
plate containing Optimum Cryosectioning Temperature (O.C.T.) mounting medium 
(Sakura). During equilibrating, a flat O.C.T. platform with a diameter of 5 cm was 
made by freezing a thin layer of O.C.T. medium onto the lid of a plastic petri-dish at 
-80°C. The flat O.C.T. platform was then transferred to a petri-dish filled with dry ice. 
A blob of O.C.T. solution was then applied to the flat platform. Immediately before 
the O.C.T. blob solidified, a second spherical blob of O.C.T. was applied on top of 
the solidifying one. Fly heads were then transferred immediately from the dissection 
plate to the second freezing O.C.T. blobs in an orientation that ocelli facing upward 
and antennae facing forward. The solidified O.C.T. blobs were then submerged in 
liquid nitrogen for a few seconds to ensure complete freezing of O.C.T.. The double 
O.C.T. blobs containing fly heads would detach from the flat platform, and were then 
collected and stored in a 15 ml Falcon tube at -20°C. Cryosectioning was performed 
within a week after embedding to avoid dehydration of samples. 
The embedded fly heads were sectioned with a cryostat (HM505E, Microm) 
and 12 jiim sections were collected. Fly head sections were recovered on a glass slide 
pre-coated with 1% gelatin (w/v) in IX PBS, fixed in 3.7% formaldehyde in IX PBS 
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for 15 minutes at room temperature, and then washed briefly in IX PBS for three 
times. The sections were blocked with PBS-GS (section 2.10.6) for 1 hr at room 
temperature, and then incubated with rabbit anti-HA primary antibody (1:250; 
Zymed) in PBS-GS overnight at 4°C. The sections were washed four times in 
PBS-GS, each for 5 min, followed by FITC-conjugated goat anti-rabbit IgG (H+L) 
secondary antibody (1:250; Zymed) incubation in PBS-GS for 2 hr at room 
temperature, and then 4'-6-Diamidino-2-phenylindole staining (DAPI; 1:75; Sigma) 
for another 2 min at room temperature. The sections were further washed four times 
in PBS-GS, each for 5 min. A volume of 40 |LI1 of Prolong Antifade Kit (Molecular 
Probes) reagent was applied onto the sections as the mounting medium. The sections 
were then covered with a glass cover slip, sealed with nail polish, and examined 
under a fluorescence microscope (Olympus BX51) equipped with a 40X/ NA 0.75 
objective. Images of the retinal sections were captured by a SPOT Insight CCD 
camera (Diagnostic Instruments Inc.) using SPOT Advanced software (version 4.1; 
Diagnostic Instruments Inc.). The images were optimized for their brightness and 
contrast on Adobe Photoshop 7.0 (Adobe) and such manipulations were applied 
across the entire image. 
The number of microscopically visible polyQ protein aggregates in each retinal 
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section was measured by the Image Pro Plus imaging software (version 5.1; Media 
Cybernetics). A fluorescent polyQ protein was defined as a fluorescence object with 
an area ranges from 6 to 100 square units, and roundness of 0 to 1.5 units. Cell nuclei 
were determined by DAPI staining. Cell population with polyQ protein aggregates in 
each section was calculated by dividing the number of polyQ aggregates by the total 
number of cell nuclei counted. The depth of retina was determined by the thickness 
of the DAPI-stained retinal cell nuclei using the SPOT Advanced software (version 
4.1; Diagnostic Instruments Inc.). Four to 30 retinal sections collected from three 
independent experiments were used to calculate the mean value and s.e.m" Mean 
differences between samples were compared by two-tailed, unpaired Student's t-test 
(Microsoft Office Excel 2003). Statistical significance was demonstrated by p-value 





Linear regression (SPSS 12.0 for Windows) was performed to determine the 
correlation between fluorescent polyQ protein aggregates detected by 
immunostaining and SDS-insoluble polyQ protein determined by filter retardation 
assay (section 2.5). 
46' 
2.9 Atomic force microscopy 
Atomic force microscopy (AFM) was used to analyze the morphology of 
aggregated polyQ protein species. Proteins isolated from 100 fly heads were 
immunoprecipitated as described in section 2.4, and eluted in 40 \i\ of 2% SDS 
solution (w/v) at room temperature for 5 min. The immunoprecipitated protein 
sample was filtered through an Ultrafree-MC membrane (Millipore) with pore size of 
0.22 JXM at 13,400 X g for 4 min at room temperature. A volume of 6 |LI1 of the eluted 
proteins were spotted onto a silica wafer, and dried at room temperature for 4 min. 
The sample was then rinsed with distilled water, dried by compressed air, and imaged 
in air with a digital multimode Nanoscope III scanning probe microscope (Digital 
Instruments, Veeco Instruments Inc.) operated in a tapping mode at room 
temperature. 
The resolution of AFM scans was at 512 X 512 pixels. Images acquired were 
flattened by the Nanoscope IV software (version 5.30r3.sr3; Digital Instruments, 
Veeco Instruments Inc.). The scan data were then exported as ASCII files, and 
analyzed by the OriginPro software (version 7.5 sr6 v7.5885; OriginLab 
Cooperation). For each 5 |im X 5 fim scan field, matrix data was plotted as a 3D 
Surface/Contour plot to visualize the three-dimensional distribution of peaks, and as 
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Profiles/Image plot to measure peak height of all particles. Profiles/Image plot was 
also used to measure the length of fibrillar structures. To ensure data reproducibility, 
three images of each sample were obtained from separate locations across the silica 
wafer surface. Sample mean value and s.e.m. were determined from three 
independent experiments. Mean differences were compared by two-tailed, unpaired 
Student's t-test (Microsoft Office Excel 2003). Statistical significance was 
demonstrated by />-value of less than 0.05. 
2.10 Reagents and buffers 
2.10.1 Reagents for Drosophila culture 
Drosophila strains 
Transgenic fly strains used in this study include gmr-GAL4, 
UAS-HA-MJDtrQ27, UAS-HA-MJDtrQ61’ UAS-HA-MJDtrQ78(w), 
UAS-HA-MJDtrQ78(s), UAS-EGFP, UAS-EGFP-Q76-FLAG, UAS-GFP::lacZ.nls, 
UAS-HSPAJL, UAS-HSC70-4.K71S, UAS-P35 and tubP-GAL8Cf\ Detailed 
information of fly stocks is summarized in Table 2. 
Cornmeal-veast-glucose-agar medium 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































105 g of dextrose (10.5%, w/v), 105 g commeal (10.5%, w/v) and 21 g yeast (2.1%, 
w/v) in 900 ml of distilled water. The mixture was boiled for about 20 min, followed 
by the addition of 80 ml of 1% nipagen (methyl p-hydroxybenzoate; dissolved in 
ethanol; Sigma) as mold inhibitor, and the mixture was made up to 1 L by distilled 
water. A volume of 15 ml of fly culture medium was dispensed to a plastic culture 
vial. 
2.10.2 Reagents for RT-PCR 
Tris-Borate-EDTA (TBE) 
Stock TBE buffer (5X) was prepared by mixing 54 g of Tris-base (0.45 M), 27.5 
g of boric acid (0.45 M) and 20 ml of 0.5 M ethylenediaminetetraacetic acid (EDTA; 
10 mM) in 1 L of double distilled water. The pH value was calibrated to 8.0. Working 
TBE solution (IX) was prepared by diluting the stock buffer 5-fold with double 
distilled water. Both stock and working solutions were kept at room temperature. 
DNA loading dye 
DNA loading dye (6X) was prepared by mixing 25 mg of bromophenol blue 
(0.25%, w/v), 25 mg of xylene cyanol FF (0.25%, w/v), 4 g of sucrose (40%, w/v) 
and 1.2 ml of 0.5 M EDTA (60 mM; pH 8.0) in 10 ml of autoclaved double distilled 
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water. Loading dye was stored as l-ml aliquots at -20°C while the working dye 
solution was kept at 4°C. 
Agarose gel 
One percent agarose gel (w/v) was prepared by melting 0.2 g of agarose 
(Bio-Rad Laboratories) in 20 ml of IX TBE by microwave for about 2 min. The 
mixture was cooled to hand-warm, and about 2 jxl of ethidium bromide (10 mg/ml; 
stored in dark at room temperature) was added to the gel solution. The gel was set on 
a gel caster (Bio-Rad Laboratories) at room temperature. 
DNA Ladder 
The working solution of either 100 base-pair or 1 kilobase-pair DNA marker 
(Fermentus) was prepared by mixing 1 volume of the stock DNA marker, 1 volume 
of 6X DNA loading dye and 4 volumes of autoclaved double distilled water. Stock 
DNA marker was kept at -20�C while the working solution was stored at 4°C. 
Primers 
Oligonucleotide primers were synthesized from Invitrogen. The lyophilized 
primer powders were reconstituted in autoclaved double distilled water to a stock 
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concentration of 100 )iM. Working primer solution of 10 pM was prepared by 
diluting the stock solution by 10-fold with autoclaved double distilled water. Both 
stock and working solutions were kept at -20°C. 
DEPC-treated water 
Diethyl pyrocarbonate (DEPC; USB) was added to double distilled water at a 
volume ratio of 1:1,000 to give a 0.1 % DEPC (v/v) water, and stirred overnight to 
disperse the DEPC. The water was then autoclaved to inactivate DEPC. Autoclaved 
DEPC-treated water was stored at room temperature. 
2.10.3 Reagents for SDS-PAGE 
SDS sample buffer 
SDS sample buffer (6X) was prepared by mixing 10 mg of bromophenol blue 
(0.02%, w/v), 5 ml of 1 M Tris-HCl; pH 6.8 (0.1 M), 10 ml of 10% SDS solution 
(w/v) (2%, w/v), 10 ml of glycerol (20%, v/v) and 2.5 ml of j8 -mercaptoethanol 
(5%, v/v) in 50 ml of double distilled water. The buffer was stored as 1.5-ml aliquots 
at -20°C. 
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SDS electrophoresis buffer 
Stock SDS electrophoresis buffer (lOX) was prepared by dissolving 30.28 g of 
Tris-base (0.25 M), 144.13 g of glycine (1.92 M) and 10 g of SDS (1%, w/v) in 1 L 
of double distilled water. Working SDS electrophoresis buffer (IX) was prepared by 
diluting the stock buffer 10-fold with double distilled water. Both stock and working 
solutions were kept at room temperature. 
Running gel solution 
For each 1.5 mm mini gel, running gel solution was freshly prepared by mixing 
3.5 ml of 30% acrylamide (12% final, v/v)，3.255 ml of 1 M Tris-HCl; pH 8.8 (0.4 
M)，1.9 ml of double distilled water, 87.5 i^l of 10% SDS solution (w/v) (1%, w/v), 
35 |Lil of 10% (w/v) ammonium persulfate (APS; 0.04%) and 4 of 
N,N,N',N'-Di-(dimethylamino)ethane (TEMED). ,, 
Stacking gel solution 
For each 1.5 mm mini gel, stacking gel solution was freshly prepared by mixing 
0.49 ml of 30% acrylamide (4% final, v/v), 0.966 ml of 0.1 M Tris-HCl; pH 6.8 (0.03 
M), 1.96 ml of double distilled water, 35 |il of 10% SDS solution (w/v) (1%, w/v), 14 
|Lil of 10% (w/v) APS (0.04%) and 4 |LI1 of TEMED. 
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Transfer buffer 
Stock transfer buffer (lOX) was prepared by dissolving 30.28 g of Tris-base 
(0.25 M) and 144.13 g of glycine (1.92 M) in 1 L of double distilled water. Stock 
solution was kept at room temperature. Working transfer buffer (IX) was freshly 
prepared by mixing 70 ml of lOX stock transfer buffer, 70 ml of methanol and 560 
ml double distilled water together. 
Tris-Buffered Saline (TBS) 
Stock TBS buffer (lOX) was prepared by dissolving 24.22 g of Tris-base (0.2 M) 
and 80.06 g of Sodium Chloride (NaCI; 1.37 M) in 1 L of double distilled water with 
pH adjusted to 7.6. IX working TBS buffer (IX) was prepared by diluting the stock 
solution 10-fold with double distilled water. Both stock and working solutions were 
kept at room temperature. 
Tris-Buffered Saline-Tween-20 (TBS-D 
TBS-T solution was prepared by adding 0.5 ml of Tween-20 (0.05% final, v/v) 
to 10 ml of IX TBS. It was kept at room temperature. 
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Blocking buffer 
Blocking buffer was prepared by dissolving 5 g of non-fat milk powder (5% 
final, w/v) in 100 ml of IX TBS. It was kept for a week at 4®C. 
2.10.4 Reagents for immunoprecipitation 
Lysis buffer 
Lysis buffer was prepared by mixing 6.06 g of Tris-base (50 mM), 8.77 g of 
NaCl (0.15 M), 2 ml of 0.5 M EDTA; pH 8.0 (1 mM) and 0.2 ml of Nonidet P-40 
(NP-40; 0.02%, v/v) in 1 L of double distilled water with pH adjusted to 7.6. It was 
kept at 4°C. 
2.10.5 Reagents for filter retardation assay 
Filter retardation sample buffer 
Filter retardation sample buffer was prepared by dissolving 0.46 g of 
dithiothreitol (DTT; 50mM) in 60 ml of 2% SDS solution (w/v). The buffer was 
stored as 1.5-ml aliquots at -20°C. 
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2.10.6 Reagents for isolation and solubilization of SDS-insoluble protein 
Protein extraction sample buffer 
Protein extraction sample buffer was prepared by dissolving 0.46 g of DTT 
(50mM) in 60 ml of 2% SDS solution (w/v). The buffer was stored as 1.5-ml aliquots 
at -20°C. 
2.10.7 Reagents for sucrose gradient sedimentation 
Sample buffer 
Sample buffer was prepared by dissolving 6.06 g of Tris-base (50 mM), 8.77 g 
of NaCl (0.15 M), 2 ml of 0.5 M EDTA; pH 8.0 (1 mM) and 100 g of sucrose (10%, 
w/v) in 1 L of double distilled water with pH adjusted to 7.6. It was kept at 4�C. 
Sucrose gradient buffers 
Sucrose gradient buffers were prepared by dissolving 6.06 g of Tris-base (50 
mM), 8.77 g of NaCl (0.15 M), 2 ml of 0.5 M EDTA; pH 8.0 (1 mM) and different 
amount of sucrose (10%, 20%, 30%, 40%, 50%, w/v) in 1 L of double distilled water 
with pH adjusted to 7.6. The buffers were kept at 4°C. 
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2.10.8 Reagents for immunofluorescence analysis 
Phosphate-Buffered Saline (PBS) 
lOX PBS solution was prepared by dissolving 80.06 g of NaCl (1.37 M), 2 g of 
Potassium Chloride (KCl; 27 mM), 26.8 g of Sodium Phosphate dibasic heptahydrate 
(Na2HP04.7H20; 0.1 M) and 2.4 g of Potassium Phosphate monobasic anhydrous 
(KH2PO4； 20 mM) in 1 L of double distilled water with pH adjusted to 7.4. IX PBS 
solution was prepared by diluting the lOX stock PBS solution 10-fold. Both stock 
and working solutions were kept at 4�C. 
Phosphate-Buffered Saline- Triton X-100 (TBS-D 
PBS-T solution was prepared by adding 30 |LI1 of Triton X-100 (0.3% final, v/v) 
to 10 ml of IX PBS. It was kept at 4°C. 
Phosphate-Buffered Saline-Goat Serum (PBS-GS) 
PBS-GS solution was freshly prepared by adding 30 |il of Triton X-100 (0.3% 
final, v/v) and 0.5 ml of goat serum (5% final, v/v; Sigma) to 10 ml of IX PBS. It 
was kept at 4�C. 
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3. RESULTS 
3.1 Establishment of an inducible transgenic Drosophila model of 
polyglutamine diseases 
3.1.1 Introduction 
Glass multiple reporter (gmr)-GAL4 drives UAS-transgene expression in 
Drosophila eye, starting from the third-instar larval developmental stage (Ellis et al., 
1993). Constitutive expression of the truncated form of expanded human 
Machado-Joseph Disease (MJD)/spinocerebellar ataxia type 3 gene product 
(MJDtrQ61 or MJDtrQ78) under the control of gmr-GALA driver, caused 
microscopically visible polyQ aggregate formation in larval imaginal eye discs, and 
degenerative phenotypes in adult retina (Figure 7A, C, D; reviewed by Bilen and 
Bonini, 2005). It is however notable that the Drosophila eye remodels during 
metamorphosis (i.e. during pupal stage; Figure 6; reviewed by Bangs and White, 
2000; Campos-Ortega, 1980)，so it would be more appropriate to study the 
relationship between polyQ protein aggregation and degeneration in a single 
developmental stage. As it is practically difficult to monitor degenerative phenotypes 
in larval and pupal stages, a method to delay MJDtrQ78 transgene expression until 
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adult stage is desirable in order to examine simultaneously both polyQ protein 
aggregation and degeneration. This strategy also allows a continuous longitudinal 
study of polyQ protein aggregation and degeneration. 
In this study, the inducible TARGET system was used to drive MJDtrQ61 and 
MJDtrQ78 transgene expression during adult stage. To characterize of this inducible 
model, Western blot analysis was performed to check for protein expression; 
immunofluorescence analysis and filter retardation assay were employed to monitor 
polyQ protein aggregation; observation of external eye depigmentation and retinal 
morphology, and pseudopupil assay were used to examine polyQ-mediated 
degenerative phenotypes. 
3.1.2 Results 
3.1.2.1 GAL80'®-mediated inducible expression of expanded polyglutamine 
protein in Drosophila 
3.1,2.1.1 GAL8(f controls GAL4/UAS-mediatedpolyQ protein expression 
In the TARGET system, relative abundance of GAL4 and GAL80'® proteins 
determines the level of UAS-transgene expression (McGuire et al., 2004). 
Independent GAL80^ transgenic fly lines can have different levels of GALSO®^  
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protein expression due to positional effects of transgene integration. Five 
independent GAL80^ ® lines were obtained from the Bloomington Drosophila Stock 
Center, USA (Table 2); pilot experiments were performed to select appropriate 
GALSQts lines based on their effectiveness to repress both polyQ protein aggregation 
and degenerative phenotype, which are the two most characterized approaches to 
monitor the expanded polyQ protein expression in Drosophila (reviewed by Bilen 
and Bonini, 2005). 
Expression of either MJDtrQ78 or MJDtrQ61 protein caused a substantial 
accumulation of microscopically visible polyQ aggregates in adult fly retina (Figure 
7B); however MJDtrQ78 led to a collapse of the retinal structure while MJDtrQ61 
caused only a modest disruption (Figure 7C). The effectiveness of GAL80^^ to 
repress microscopically visible protein aggregate formation was therefore assessed 
on a relatively intact retinal structure using MJDtrQ61 -expressing, in preference to 
MJDtrQ78-expressing, fly eyes. At 18°C (a permissive temperature for the action of 
GAL80巧，no aggregates were observed in flies with gmr-GAL4, UAS-MJDtrQ61 and 
any of the five GAL8(f transgenes (Figure 8A). Meanwhile, the expression of 
MJDtrQ78 protein resulted in severe depigmentation in adult fly external eyes 
(Figure 7A; Figure 8B). Flies bearing gmr-GAL4, UAS-MJDtrQ78 and each of the 
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Figure 8. GALSOts represses the polyglutamine protein expression 
in Drosophila. (A) Immunofluorescence analysis of the adult fly 
retina at 18®C (a permissive temperature for the action of GALSOts). 
In the absence of GALSOts, expression of MJDtrQ61 led to the 
formation of polyQ aggregates (shown in green) at 2 to 3 days post-
eclosion (dpe). In the presence of GALSOts, no polyQ aggregates 
were detected. Scale bars represent 50 iim. The flies were of 
genotypes w; gmr-GAL4 UAS-MJDtrQ61 /+; +/+ and w; gmr-GAL4 
UAS-MJDtrQ61/+; tubP-GAL80ts/+. (B) Observation of the adult 
external fly eye at 25 (a partially permissive temperature for the 
action of GALSOts). Expression of MJDtrQ78 caused eye 
depigmentation at 2 to 3 dpe. No external eye depigmentation 
phenotype was observed in MJDtrQ78 flies co-expressed with 
GALSOts. The flies were of genotypes w; gmr-GAL4 UAS-
MJDtrQ78(s)/+; +/+ and w; gmr-GAL4 UAS-MJDtrQ78(s)/+; tubP-
GAL80ts/+. 
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five GAL8(f transgenes did not acquire any observable eye depigmentation, even 
when they were raised at a partially permissive temperature for the action of GALSO^ 
(i.e. 25�C) which increases the GAL4 to GAL80坊 activity ratio (Figure 8B). 
Altogether, these data demonstrate that all five GAL80^ ® lines can effectively restrict 
the expression of expanded polyQ protein as evidenced by its effect on polyQ protein 
aggregation and degeneration. For the simplicity of fly stock generation for 
subsequent analysis, one of the GAL80^ ® lines (Bloomington stock number: 7018) 
was chosen for further characterization. 
3.1.2.1.2 Inducible expression of SDS-soluble expanded polyglutamine protein 
Expression of MJDtrQ78 transgene was induced when flies carrying the 
gmr-GAL4, UAS-MJDtrQ78 and GALSO" transgenes were transferred from 18°C to 
25°C. Western blot analysis was performed to examine the expression profile of 
expanded polyQ protein. SDS-soluble MJDtrQ78 protein (with a predicted molecular 
weight of about 35 kJDa) was not detected at the running gel portion upon 25°C 
induction within 12 days post-induction (dpi; Figure 9A), which could be explained 
by the low level of MJDtrQ78 protein expression. Therefore, immunoprecipitation 
was performed to detect the MJDtrQ78 protein; SDS-soluble MJDtrQ78 protein was 
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Figure 9. Induced expression of the MJDtrQ78 protein in adult flies. 
(A) Western blot analysis of the MJDtrQ78 protein extract of adult flies. 
A progressive accumulation of SDS-insoluble MJDtrQ78 protein was 
detected from 4 days post-induction (dpi) onward (stacking gel; indicated 
by bar). /3 -tubulin was used as the loading control. The significant 
difference in the level of SDS-insoluble MJDtrQ78 protein between 4 and 
12 dpi was determined by the quantification of signal intensity ratio of 
MJDtrQ78 protein at stacking gel portion to -tubulin (*/? < 0.05; 
unpaired Student's t-test). No SDS-soluble monomeric MJDtrQ78 
protein (of about 35 kDa; indicated by arrow) was detected. (B) 
Immunoprecipitation of the MJDtrQ78 protein extract of adult flies. A 
significant amount of SDS-soluble monomeric MJDtrQ78 protein (of 
about 35 kDa) was eluted at 4 dpi, but not at 0 or 12 dpi (*p < 0.05 for 
each comparison; unpaired Student's t-test). Error bars represent the 
mean 土 s.e.m. of three independent experiments. The flies were of 
g e n o t y p e w ; gmr-GAL4 UAS-MJDtrQ7 8 (s) tubP-
GAL80ts/+. 
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demonstrates the expression of SDS-soluble MJDtrQ78 protein upon induction. 
Since SDS-soluble MJDtrQ78 protein was only detected upon 25�C induction but not 
at 18�C (Figure 9B), this further confirms the effectiveness of the GAL80^' line to 
repress GAL4/UAS-mediated poIyQ transgene expression, and that the repression is 
relieved by temperature shift from 18°C to 25�C. 
3.1.2.1.3 Induced expression of expanded polyglutamine protein accumulates 
gradually in form of SDS-insoluble protein 
As shown in Figure 9B, SDS-soluble MJDtrQ78 protein was detected at 4 dpi 
but its level diminished at 12 dpi. Along the same time frame of induction, a 
concomitant progressive accumulation of SDS-insoluble MJDtrQ78 protein was 
observed in the stacking gel portion from 4 dpi onwards (Figure 9A). It is possible 
that the expanded polyQ protein accumulates in SDS-insoluble form with time. To 
verify this, a filter retardation assay (Wanker et al., 1999) was performed to detect 
SDS-insoluble polyQ protein. In this assay, SDS-insoluble protein with size larger 
than the pore size of the cellulose acetate membrane (0.22 |im) would be retained on 
the membrane. In this inducible model, a progressive accumulation of SDS-insoluble 
MJDtrQ78 protein was observed from 1 to 4 dpi (Figure 10). Altogether, these data 
illustrate that the induction of MJDtrQ78 transgene expression in adult flies 
66' 
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Figure 10. Induced expression of MJDtrQ78 causes progressive 
accumulation of SDS-insoluble protein. Detection of SDS-
insoluble MJDtrQ78 protein in the adult fly protein extract using 
filter retardation assay. An increasing amount of SDS-insoluble 
MJDtrQ78 protein was retained on an 0.22-^m filter membrane 
from 1 to 4 days post-induction (dpi). Error bars represent the 
mean 士 s.e.m. of three independent experiments. The flies were of 
g e n o t y p e w; gmr-GAL4 UAS-MJDtrQ78(s)/+; tubP-
GAL80ts/+. 
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promotes a temporal accumulation of SDS-insoluble polyQ protein. 
3.1.2.1.4 Inducible expression of expanded polyglutamine protein results in 
progressive accumulation of microscopically visible aggregates 
Formation of microscopically visible aggregates is a hallmark feature of polyQ 
diseases (reviewed by Ross and Poirier, 2004). In this inducible MJDtrQ78 model, 
polyQ-immunoreactive protein aggregates were first detected in retinal neurons at 2 
dpi, and accumulated progressively with time (Figure 11). This data demonstrates the 
tendency of expanded polyQ protein to accumulate as microscopically visible 
aggregates. 
3.1.2.2 Inducible expression of expanded polyglutamine protein causes 
late-onset progressive neuronal degeneration in Drosophila 
3.1.2.2.1 Inducible expression of expanded polyglutamine protein leads to 
late-onset progressive deterioration of photoreceptor neurons 
In Drosophila, each compound eye is comprised of about 800 repeating optical 
arrays called ommatidia. Each ommatidium contains a set of photoreceptor neurons 
in which rhabdomeres refer to the photosensitive organelles enriched with rhodopsin 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































al., 2006). Pseudopupil assay is a widely used method to assess the functional 
integrity of rhabdomere structure in adult fly eyes (Agrawal et al., 2005; Apostol et 
al., 2003; Boeddrich et al., 2006; Jackson et al., 1998; Slepko et al., 2006; Steffan et 
al., 2001; Wolfgang et al., 2005), and has been employed to measure polyQ-mediated 
cellular degeneration before cell death (Berger et al., 2005). In degenerating 
photoreceptor neurons, the rhabdomere structure would be disrupted and cannot be 
detected using pseudopupil assay. The number of visible rhabdomeres per 
ommatidium has an inverse correlation with the functional intactness of the retinal 
neurons, is therefore a quantitative measurement of neuronal degeneration. 
Continuous induction of MJDtrQ78 transgene expression reduced the average 
number of rhabdomeres per ommatidium count at 12 dpi, and the effect became more 
evident at 18 dpi (Figure 12B). Control flies bearing no MJDtrQ78 transgene 
retained a normal number of rhabdomeres per ommatidium up to 18 dpi (Figure 12B), 
suggesting that the decline brought by MJDtrQ78 expression was not due to normal 
aging. To sum up, MJDtrQ78 expression initiated progressive deterioration of 
photoreceptor neurons from 12 dpi. 
71' 
3.1.2.2.2 Inducible expression of expanded polyglutamine protein neither causes 
external eye degenerative phenotype nor disrupts gross retinal 
morphology despite deterioration of photoreceptor neurons 
Constitutive expression of MJDtrQ78，but not MJDtrQ27, led to depigmentation 
of external adult eyes (Figure 7A) and collapse of the internal retinal structure 
(Figure 7C) that are reliable indicators of cell death in pigment cells and 
photoreceptor neurons respectively. Interestingly though, neither external eye 
depigmentation (Figure 13 A) nor significant collapse of the internal retinal structure 
(Figure 13B, C; indicated by the retinal depth; Boeddrich et al., 2006; 
Fernandez-Funez et al., 2000; Warrick et al., 2005) were observed within 12 dpi of 
MJDtrQ78 expression. Induction of MJDtrQ78 expression did not therefore result in 
significant cell death within 12 dpi, at the time when deterioration of rhabdomeric 
structures occurred (Figure 12). 
3.1.2.3 Co-expression of caspase inhibitor P35 suppresses 
polyglutamine-induced neuronal degeneration 
Caspase activation is associated with polyQ-mediated degeneration (reviewed 
by Ross, 2002). Co-expression of a caspase inhibitor protein P35 (Mergliano and 
Minden, 2003) significantly rescued the loss of rhabdomeres in 
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Figure 13. Induced expression of MJDtrQ78 does not cause external 
eye depigmentation and disruption of gross retinal morphology. (A) 
Observation of the adult external fly eye. The induction of MJDtrQ78 
expression did not cause eye depigmentation at 12 days post-induction 
(dpi). (B) Monitoring of the adult fly retinal morphology under 
fluorescence microscopy. No alteration in the depth of the retina 
(indicated by double-headed arrows) was observed within 12 dpi of 
MJDtrQ78 expression. DAPI was used to label the cell nuclei (shown in 
red). This method has been commonly used to assess retinal cell death 
(Boeddrich et al. (2006); Femandez-Funez et al. (2000); Warrick et al. 
(2005)). Scale bars represent 30 /zm. The flies were of genotype w; gmr-
GAL4 UAS'MJDtrQ78(s)l+\ tubP-GAL80ts/+. (C) Quantification of (B)， 
Figure 7C and Figure 11. Error bars represent the mean 土 s,e.m. of three 
independent experiments. (*p < 0.05 for each comparison; unpaired 
Student's t-test). 
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MJDtrQ78-expressing retinal neurons at 12 dpi (Figure 14). No such rescue was 
observed when an unrelated GFP-IacZ fusion protein was co-expressed (Figure 14), 
which indicates that the suppressive effect mediated by P35 was specific. Meanwhile, 
co-expression of P35 could no longer ameliorate MJDtrQ78-induced deterioration of 
photoreceptor neurons at 18 dpi (Figure 14). These results indicate that the early 
stage of neuronal degeneration induced by MJDtrQ78 expression is, to a certain 
extent, associated with caspase activation. 
3.1.2.4 Co-expression of molecular chaperone Hsp70 suppresses 
polyglutamine-induced neuronal degeneration 
Molecular chaperone Hsp70 is a potent suppressor of polyQ-mediated neuronal 
degeneration (reviewed by Muchowski and Wacker, 2005). In this inducible model, 
co-expression of Hsp70 restored the normal number of rhabdomeres per ommatidium 
count in MJDtrQ78-expressing flies at 12 dpi, but not at 18 dpi (Figure 14). This is 
also consistent with the finding that Hsp70 delayed polyQ-mediated pigment cell 
degeneration in the constitutive MJDtrQ78 model (Huen and Chan, 2005)，and 
further demonstrates that Hsp70 only delays, but not completely prevents, 
degeneration of neurons. 
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Figure 14. The effect of caspase inhibitor P35 and molecular 
chaperone Hsp70 on MJDtrQ78-induced deterioration of 
rhabdomere integrity. Assessment of rhabdomere integrity using 
pseudopupil assay. The induced expression of MJDtrQ78 resulted in 
a reduction in the average number of rhabdomeres per ommatidium 
count in adult fly eye at 12 days post-induction (dpi). Co-expression 
of the caspase inhibitor P35 and molecular chaperone Hsp70 protein, 
but not the control GFP-lacZ fusion protein, with MJDtrQ78 rescued 
the average number of rhabdomeres per ommatidium count at 12 dpi 
(*p < 0.05 for comparison between MJDtrQ78 and MJDtrQ78 + P35, 
as well as for comparison between MJDtrQ78 and MJDtrQ78 + 
Hsp70, at the specified time point; Mann-Whitney U-test). Error bars 
represent the mean 土 s.e.m. of three independent experiments. The 
flies were of genotypes w; gmr-GAL4 UAS-MJDtrQ78(s)/+; tubP-
GAL80ts/+, w\ gmr-GAL4 UAS-MJDtrQ78(s)/UAS-GFP::lacZ.nls; 
tubP-GAL80ts/+, w; gmr-GAL4 UAS-MJDtrQ78(s)/+; tubP-
GAL80tslUAS-P35, and w; gmr-GAL4 UAS-MJDtrQ78(s)/UAS-
HSPAIL： tubP-GAL80ts/+. 
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3.1.2.5 Inducible expression of expanded polyglutamine protein results in 
biphasic expression of molecular chaperone Hsp70 in Drosophila 
Our laboratory and others have employed the Drosophila model with 
constitutive expression of expanded polyQ proteins to dissect polyQ-mediated 
pathogenic consequences (reviewed by Bilen and Bonini, 2005; Marsh and 
Thompson, 2006). For instance, in flies with constitutive expression of MJDtrQ78, 
1 
an up-regulation of Hsp70 protein level was detected which then decline ：' 
progressively due to the polyQ-mediated transcriptional dysregulation of Hsp70 gene 
；; 
induction (Huen and Chan, 2005). Here, in this inducible model of MJDtrQ78, such 
1 
biphasic expression of Hsp70 protein level was also observed. A progressive 
j 
J 
elevation of Hsp70 protein level was found at 2 dpi (Figure 15). The induction of I 
1 
I； 
Hsp70 protein peaked at 3 dpi, and then started to decrease at 4 dpi and declined fj 
dramatically at 12 dpi (Figure 15). This observation shows that this inducible model ,J 
recapitulates polyQ-mediated pathogenic events as previously described (Huen and 
Chan, 2005). 
3.1.3 Discussion 
To elucidate the relationship between polyQ-mediated neurodegeneration and 
protein aggregation in a Drosophila. model in vivo, it would be desirable to study 
76' 
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Figure 15. Induced expression of MJDtrQ78 results in biphasic 
expression profile of molecular chaperone Hsp70 protein. 
Immunoblotting analysis of the endogenous level of Hsp70 protein in 
MJDtrQ78-expressing flies. The induction ofMJDtrQ78 expression led to 
an elevation of the level of HspVO protein at 4 days post-induction (dpi), 
and declined at 12 dpi. Hsp70 protein induction was further shown to 
start increase at 2 dpi, peak at 3 dpi, and then decrease since 4 dpi. /3 -
tubulin was used as the loading control. Error bars represent the mean 土 
s.e.m. of three independent experiments. The flies were of genotype w; 
gmr-GAL4 UAS-MJDtrQ78(s)/+\ tubP-GAL80ts/+. 
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these two parameters in a single developmental stage. An inducible Drosophila 
model was recently reported to recapitulate SCA 7 pathogenesis (Latouche et al., 
2007). In the SCA 7 model, the Gene-Switch inducible expression system (Latouche 
et al., 2007) was employed in which the transgene expression was induced by 
feeding adult flies with drugs. Drug dosage variation among individual flies could 
however be a major source of errors in this inducible expression system. 
In this study, an inducible Drosophila model of MJD was established by the use 
of another transgene induction strategy called TARGET (McGuire et al., 2003). One 
advantage of the TARGET system over the Gene-Switch system is that transgene 
expression can be controlled simply by temperature shift, which is devoid of the 
problem of dosage variation. In the TARGET expression system, ideally, the i 
expression level of polyQ protein should remain minimal at low temperature (i.e. at 
18°C in this study) when the GAL80^' protein binds to the GAL4 protein and thus 
impedes the GAL4-mediated transcriptional activation of the UAS-transgene. Apart 
from the repressive mechanism by GALSQts, GAL4/UAS expression is itself 
temperature-dependent (Brand et al., 1994). Only a low expression level of the 
UAS-transgene occurs at a low temperature. This serves as an additional mechanism 
to ensure the UAS-transgene expression is kept at a minimal level at 18�C. As 
78' 
ascertained by Western blot analysis, MJDtrQ78 protein was not detected in flies 
co-expressed with MJDtrQ78 and GAL8(f at 0 dpi (Figure 9A，B). This therefore 
confirms the practical utilization of this inducible MJDtrQ78 model. On the other 
hand, the leakiness of the GAL80*® system at 25�C (i.e. a partially permissive 
temperature for the action of GAL80�McGuire t al., 2004) makes it possible to 
manipulate the GAL80^® to GAL4 activity ratio, and thus the inducible expression of 
MJDtrQ78 transgene, to a desired level in order to monitor polyQ toxicity at a longer 
time period in detail. 
Inducible expression of MJDtrQ78 allowed temporal analysis on the 
aggregation kinetics of the expanded polyQ protein. In both a filter retardation assay 
(Figure 10) and immunofluorescence analysis (Figure 11)，a lag phase of about 1 day 
was observed for the initial appearance of polyQ-immunoreactive protein. 
Meanwhile, the accumulation of polyQ protein approached a plateau level at 4 dpi. 
This kinetic behavior is consistent with a nucleated polymerization reaction as 
described for the expanded polyQ protein in vitro (Chen et al., 2002; Ellisdon et al., 
2006; Scherzinger et al., 1999; Slepko et al., 2006). This result therefore 
demonstrates that aggregation of the expanded polyQ protein is initiated by a 
nucleation process in vivo. 
79' 
While the expanded polyQ protein tends to accumulate in SDS-insoluble, but 
not SDS-soluble form (Figures 9; Figure 10), a positive correlation between temporal 
accumulation of microscopically visible aggregates and SDS-insoluble polyQ protein 
retained by filter retardation assay was further demonstrated (Figure 16). This finding 
implies that aggregation of the expanded polyQ protein involves a change in protein 
solubility properties. 
I 
Previously shown in the fly model with constitutive expression of MJDtrQ78, | 
i 
microscopically visible protein aggregates were detected in larval stage and • 
I 
degenerative phenotypes were observed in adult stage (Warrick et al., 1998). In ,j 
3 
. t ； J 
support of this, this inducible MJDtrQ78 model provides further evidence that these | 
:i 
protein aggregates were formed before degenerative phenotypes were observed in | 
neurons (Figure 11; Figure 12). Meanwhile, the neurodegenerative phenotype J 
detected was distinct from cell death (Figure 13). MJDtrQ78-induced degeneration 
occurred at 12 dpi, but not later at 18 dpi, was modulated by the co-expression of 
molecular chaperone Hsp70 or caspase inhibitor P35 (Figure 14). This observation 
suggests that disturbance of cellular protein folding machineries (Figure 15; Huen et 




§ 1 T 
o g-tfT ‘ ^ x 一 • 
111 ——“• 
O CD S / 
c > 10 .…-Z—— 
E 旦 I 0 L ^ . ‘ i 
0 5 10 16 
Filter retardation assay I 
(relative signal intensity) ： 
i 
I： 
Figure 16. A linear correlation between accumulation of j 
SDS-insoluble MJDtrQ78 protein and microscopically j 
visible protein aggregates. An X-Y plot of data from Figure ‘ 
10 and Figure 11. A linear relationship {R^ 二 0.985; p < ' 
0.001) between the amount of SDS-insoluble MJDtrQ78 
protein (i.e. detected using filter retardation assay; X-axis) 
and the population of cells with MJDtrQ78 aggregates (i.e. 
detected using immunofluorescence; Y-axis) can be observed. 




To conclude, results in this section demonstrate that this inducible MJDtrQ78 
model recapitulates many features of polyQ-mediated pathogenic events, including 
accumulation of microscopically visible polyQ protein aggregates (Figure 11)， 
progressive neurodegeneration (Figure 12), Hsp70- and P35-mediated suppression of 
the early stage of polyQ degeneration (Figure 14)，and biphasic expression of Hsp70 
protein (Figure 15). This inducible model would therefore be an invaluable tool to 
1 
investigate pathogenic events brought by the expanded polyQ protein expression in ‘ 
I 












3.2 Involvement of microscopically visible polyglutamine 
aggregates in neurodegeneration 
3.2.1 Introduction 
Accumulation of microscopically visible protein aggregates in neurons has long 
been recognized in polyQ pathogenesis (reviewed by Ross and Poirier, 2004). 
Current understanding of the role of microscopically visible protein aggregates in 
polyQ pathogenesis have been discussed in section 1.3. In this section, the role of 
these polyQ aggregates in neuronal degeneration was evaluated in the inducible 
Drosophila model. 
3.2.2 Results 
3.2.2.1 Effect of Hsc70-K71S on microscopically visible polyglutamine 
aggregates and neuronal degeneration 
3.2Z 1.1 Co-expression of Hsc70-K71S reduces the level of microscopically visible 
polyglutamine aggregates 
In order to examine the role of microscopically visible protein aggregates in 
polyQ-mediated neuronal degeneration, it is important to find out ways to manipulate 
the abundance of these polyQ aggregates. Hsp70 is an ATPase that plays roles in 
83' 
protein folding and degradation in cells (reviewed by Bukau et al., 2006; Young et al., 
2004). A substitution mutation (K71S; lysine to serine residue at position 71) in the 
ATPase domain of Hsp70 has previously been shown to impair its protein folding 
activity, but not its protein degradation function (Klucken et al., 2004). It has also 
been found that an ATPase domain deletion mutant of Heat shock cognate 70 (Hsc70; 
a constitutively expressed form of Hsp70) interacts with the expanded polyQ protein 
and suppressed its aggregation in vitro (Jana et al., 2000). When MJDtrQ78 and 
Hsc70-K71S mutant proteins were co-expressed in the adult retina under the control 
of GAL80ts，a significant reduction in the number of polyQ aggregate-containing 
cells was observed (Figure 17). This demonstrates that co-expression of Hsc70-K71S 
is capable of restricting the level of microscopically visible MJDtrQ78 aggregates. 
3.2.2.1.2 Co-expression of Hsc70-K71S does not alter polyglutamine transgene 
expression 
Manipulations that alter MJDtrQ78 transgene expression would inevitably 
modify the level of MJDtrQ78 protein aggregates. Using RT-PCR, comparable level 
of MJDtrQ78 messenger RNA was detected in MJDtrQ78-expressing and 
MJDtrQ78/Hsc70-K71 S-expressing flies (Figure 18). This indicates that the action of 
Hsc70-K71S on microscopically visible MJDtrQ78 aggregates is not due to the 
84' 
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Figure 17. Co-expression of mutant Hsc70-K71S molecular 
chaperone reduces the number of microscopically visible 
MJDtrQ78 protein aggregates. Immunofluorescence analysis of 
the adult fly retinal section. The induced expression of MJDtrQ78 
resulted in aggregate formation at 12 days post-induction (dpi). The 
co-expression of Hsc70-K71S with MJDtrQ78 significantly reduced 
the percentage of cells with aggregates (shown in green) at 12 dpi 
(*p < 0.05; impaired Student t-test). DAPI was used to label the 
cell nuclei (shown in red). Double-headed arrows represent the 
depth of the retina. Scale bars represent 30 /zm. The cell population 
with aggregates was calculated by dividing the number of aggregates 
by the number of DAPI-stained cell nuclei. Error bars represent the 
mean 土 s.e.m, of three independent experiments. The flies were of 
genotypes w; gmr-GAL4 UAS'MJDtrQ78(s)l+; tubP-GAL80ts/+, 
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Figure 18. Co-expression of mutant Hsc70-K71S molecular 
chaperone does not alter MJDtrQ?8 transgene expression. 
Semi-quantitative RT-PCR analysis of extracted RNA of adult flies. 
A comparable level of expression of MJDtrQ?8 messenger RNA 
was detected in MJDtrQ78 flies at 12 days post-induction (dpi) 
with and without the co-expression of Hsc70-K71S. actin 
messenger RNA was used as the loading control. The band signal 
intensity ratio {HA-MJDtrQ78!actin) was quantified. Error bars 
represent the mean 土 s.e.m. of three independent experiments. The 
flies were of genotypes w; gmr-GAL4 UAS-MJDtrQ78(s)/+', tubP-
GAL80ts/+ and w; gmr-GAL4 UAS-MJDtrQ78(s)/UAS-Hsc70-
4.K71S; tubP-GAL80ts/+. 
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alteration of MJDtrQ78 transgene expression. 
3.2.2.1.3 Co-expression of Hsc70-K71S does not modify polyglutamine-induced 
neuronal degeneration 
To determine the effect of microscopically visible protein aggregates on 
polyQ-expressing cells, pseudopupil assay was performed to assess the degree of 
neuronal degeneration in MJDtrQ78/Hsc70-K71 S-expressing flies. If 
microscopically visible polyQ aggregates are neuroprotective, an enhancement of 
neuronal degeneration would be expected in these flies. On the contrary, if these 
aggregates are neurotoxic, neuronal degeneration would be attenuated or delayed. 
Unexpectedly, no significant difference in the average number of rhabdomeres per 
ommatidium count was observed between MJDtrQ78-expressing and 
MJDtrQ78/Hsc70-K71 S-expressing flies at all time points examined (Figure 19). 
Besides, no difference of the gross retinal structure was observed in MJDtrQ78 flies 
with and without the co-expression of Hsc70-K71S (Figure 20). All these data 
indicate that microscopically visible polyQ aggregates do not promote or delay 
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Figure 19. Co-expression of mutant Hsc70-K71S molecular 
c h a p e r o n e does not mod i fy MJDtrQ78- induced 
deterioration of rhabdomere integrity. Pseudopupil assay of 
rhabdomere integrity in the adult fly eye. The induced 
expression of MJDtrQ78 caused a progressive reduction in the 
average number of rhabdomeres per ommatidium count starting 
from 12 days post-induction (dpi). Co-expression of Hsc70_ 
K71S with MJDtrQ78 resulted in the similar average number of 
rhabdomeres per ommatidium count as in MJDtrQ78 at all time 
points examined. Error bars represent the mean 土 s.e.m. of three 
independent experiments. The flies were of genotypes w; gmr-




HA-MJPtrQ78 + + + + 
HSC70-K71S - + - + 







Q I m m b I - L M J - l a a J -
Figure 20. Co-expression of MJDtrQ78 with mutant 
HscTO-KTlS molecular chaperone does not affect gross 
retinal morphology. Monitoring of retinal morphology of the 
adult fly eye under fluorescence microscopy. At both 4 days 
post-induction (dpi) and 12 dpi, no significant alteration in the 
depth of the retina (indicated by double-headed arrows) was 
o b s e r v e d b e t w e e n M J D t r Q 7 8 - e x p r e s s i n g and 
MJDtrQ78/Hsc70-K71 S-expressing flies. DAPI was used to 
label the cell nuclei (shown in red). This method has been 
commonly used to assess retinal cell death (Boeddrich et al. 
(2006); Femandez-Funez et al. (2000); Warrick et al. (2005)). 
Scale bars represent 30 p, m. Error bars represent the mean 土 
s.e.m. of three independent experiments. The flies were of 
g e n o t y p e s w; gmr-GAL4 UAS-MJDtrQ78(s)!+ ； tubP-
• GAL80ts/+ and w; gmr-GAL4 UAS-MJDtrQ78(s)IUAS-Hsc70-
4.K71S; tubP-GAL80ts/+. 
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3.2.2.2 Microscopically visible polyglutamine aggregates do not correlate with 
neuronal degeneration 
Our group had previously established an EGFP-polyQ76-FLAG transgenic fly 
model (Lam and Chan, unpublished materials), in which an expanded polyQ protein 
containing 76 glutamine repeats was fused with the N-terminus of a FLAG tag and 
the C-terminus of enhanced green fluorescent protein (EGFP). Similar to MJDtrQ78, 
constitutive expression of EGFP-polyQ76-FLAG protein led to external eye 
depigmentation and microscopically visible protein aggregate formation (Figure 21; 
Lam and Chan, unpublished data). 
To further address the correlation between microscopically visible polyQ 
aggregates and neuronal degeneration, the possibility to simultaneously visualize 
both GFP-positive polyQ aggregates and rhabdomere integrity in the same 
EGFP-polyQ76-FLAG-expressing fly eye was explored. Under the regulation of 
GAL80ts， diffuse green fluorescent signals were observed in control 
EGFP-expressing flies at 4 dpi but not 0 dpi (Figure 22). Discrete nuclear green 
fluorescent signals were also observed when the expression of a GFP-lacZ fusion 
protein tagged with a nuclear localization signal was induced for 8 days (Figure 22). 
In EGFP-polyQ76-FLAG-expressing flies, both diffuse and distinct green fluorescent 
90' 
Constitutive expression at 25。C 
Control EGFP.Q76-FLAG mm 
Figure 21. Characterization of EGFP-polyQ76-FLAG transgenic 
Drosophila model. (A) Observation of the external eye of adult flies. 
Constitutive expression of EGFP-polyQ76-FLAG caused external eye 
depigmentation at 2 to 3 days post-eclosion (dpe), but not in the 
Control. (B) Detection of EGFP-polyQ76-FLAG aggregates in the 
larval imaginal eye disc under fluorescence microscopy. Constitutive 
expression of EGFP-polyQ76*FLAG led to the formation of GFP-
positive aggregates (shown in green). The larva and flies were of 
genotypes w; gmr-GAL4l+\ +/+ (Control) and w; gmr-GAL4/+; UAS-






























































































































































































































































































































































































































































































































signals were detected at 4 and 8 dpi (Figure 22). The distinct, rather than diffuse, 
green fluorescent signal would probably represent EGFP-polyQ76-FLAG aggregates. 
Simultaneous to the green fluorescent signal detection, the rhabdomere integrity was 
monitored in these flies and with the average number of rhabdomeres per 
ommatidium count determined (Figure 22). Collectively, these results demonstrate 
the practicability to simultaneously monitor both GFP-tagged protein and 
rhabdomeres in the fly eye. In flies expressed with EGFP-polyQ76-FLAG, statistical 
analysis revealed neither a positive nor negative correlation between GFP-positive 
polyQ aggregate formation and rhabdomere integrity (Figure 23). This data therefore 
supports a lack of association between microscopically visible polyQ aggregates and 
neuronal degeneration. 
3.2.3 Discussion 
Inducible expression of MJDtrQ78 protein formed microscopically visible 
protein aggregates (Figure 11), and its sustained expression (12 dpi and onwards) 
resulted in neuronal degeneration (Figure 12). When the number of microscopically 
visible polyQ aggregate-containing cells was reduced by the co-expression of an 
ATPase-defective mutant Hsc70 molecular chaperone protein (Figure 17), no 
modification of neuronal degeneration was observed (Figure 19; Figure 20). It was 
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Figure 23. Accumulation of polyQ aggregates is not 
correlated with deterioration of rhabdomere integrity in 
the EGFP-polyQ76-FLAG model. Detection of EGFP-
polyQ76-FLAG aggregates under fluorescence microscopy 
and rhabdomere integrity using pseudopupil assay in the same 
adult fly eye. No linear correlation was observed between the 
area occupied by GFP-positive aggregates (defined as the 
total area of green fluorescence signals over the area of a 
single ommatidium) and the average number of rhabdomeres 
per ommatidium count (R^ = 0.001; p = 0.752) in EGFP-
polyQ76-FLAG-expressing flies of 2 to 3 days post-eclosion 
(dpe). The flies were of genotype w; gmr-GAL4/+; tubP-
GAL80ts/UAS-EGFP-Q76-FLAG. 
94' 
previously reported that the K71S mutation promotes degradation of a-synuclein, an 
aggregation-prone disease protein involved in Parkinson's disease, through a 
non-proteasome inhibitor-sensitive pathway (Klucken et al. 2004). The exact 
mechanism by which Hsc70-K71S attenuated the accumulation of microscopically 
visible polyQ aggregates requires further investigation. Nevertheless, these 
MJDtrQ78 aggregates appear to play neither a neurotoxic nor protective role in 
triggering polyQ-induced neuronal degeneration. 
Microscopically visible polyQ aggregates and rhabdomere integrity were 
assessed simultaneously in an EGFP-polyQ76-FLAG fly model. Of note, this model 
reiterates several features reported for polyQ-mediated protein aggregation and 
neurodegeneration. First, both diffuse and distinct green fluorescent signals of 
EGFP-polyQ76-FLAG protein were detected at 4 dpi, with the latter signal being 
predominant at 8 dpi (Figure 22). In the view that the distinct green fluorescent 
signal corresponds to EGFP-polyQ76-FLAG aggregates, this is consistent with the 
real-time observation in a cell culture model of HD that microscopically visible 
polyQ aggregates grow by incorporation of the diffuse expanded polyQ protein 
(Schiffer et al., 2007). Second, accumulation of EGFP-polyQ76-FLAG aggregates 
was observed at 8 dpi, but the average number of rhabdomeres per ommatidium at 8 
95' 
dpi remains comparable to that at 0 dpi (Figure 22). This is again in agreement with 
that no neurodegenerative phenotype was detected despite widespread occurrence of 
microscopically visible polyQ aggregates in the inducible MJD fly model (Figure 11; 
Figure 12) and in a previously reported transgenic mouse model of HD (Slow et al., 
2005). Third, further expression of EGFP-polyQ76-FLAG protein resulted in 
degenerative phenotypes (Figure 21 A; Figure 23). All these provide further basis on 
the use of this EGFP-polyQ76-FLAG model to study polyQ protein aggregation and 
neurodegeneration. Using this model, no linear correlation between the number of 
EGFP-polyQ76-FLAG aggregates formed and neuronal degeneration was found 
(Figure 23). 
Summarizing data from the two independent fly models, proteins with expanded 
polyQ tracts form microscopically visible aggregates which do not associate with 
polyQ-induced neuronal degeneration in vivo. These findings are in line with the lack 
of correlation between neurodegeneration and microscopically visible protein 
aggregates recently described in MJD patient brain tissues (Rub et al., 2006). 
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3.3 Detection of small SDS-insoluble expanded polyglutamine 
protein species and its association with neurodegeneration 
3.3.1 Introduction 
Disease protein with an expanded polyQ tract exists in various forms (section 
1.4) which display distinct biochemical solubility properties when extracted by 
solvents such as sodium dodecyl sulfate (SDS) and formic acid (FA). Previous 
studies have established a connection between solubility properties of expanded 
polyQ protein and neurodegeneration. For example, it was found that molecular 
chaperones increased the level of SDS-soluble expanded polyQ disease protein and 
ameliorated polyQ-mediated toxicity in both transgenic Drosophila models of MJD 
(Chan et al., 2000) and SBMA (Chan et al” 2002), whereas compromised 
proteasome activity in the cell reduced the level of SDS-soluble expanded polyQ 
disease protein and enhanced polyQ-mediated degeneration in the transgenic 
Drosophila model of SBMA (Chan et al., 2002). In a knock-in mouse model of SCA 
1, SDS-solubility properties of expanded polyQ disease protein decreased with the 
disease progression (Watase et al., 2002). In brain tissues of HD patients, 
FA-insoIuble polyQ disease protein was isolated in cerebral cortex, which is one of 
the brain regions most vulnerable to degeneration in HD (Table 1), but not in 
97' 
unaffected regions such as cerebellum (luchi et al., 2003). Altogether, these 
observations highlight an association between disease protein solubility and 
neurodegeneration in polyQ pathogenesis. In this section, the relationship between 
solubility properties of the expanded polyQ protein and neuronal degeneration was 
studied in the inducible Drosophila model. 
3.3.2 Results 
3.3.2.1 Accumulation of SDS-soluble expanded polyglutamine protein does not 
correlate with neuronal degeneration 
SDS-soluble forms of the expanded polyQ protein have been widely described 
both in vitro (Behrends et al., 2006; Chai et al” 2001; Cong et al., 2006; Dehay and 
Bertolotti, 2006; Gales et al., 2005; Nagai et al., 2007; Schaffar et al., 2004) and in 
vivo (Chan et al., 2002; Chan et al., 2000; Hay et al, 2004; Lam et al” 2006; Li et al., 
2006). In the inducible fly model, monomeric SDS-soluble MJDtrQ78 protein was 
detected at 4 dpi, but not 12 dpi (Figure 9) when neuronal degeneration became 
prominent (Figure 12). This indicates that degeneration of neurons is not mediated by 
the accumulation of monomeric SDS-soluble expanded polyQ protein. 
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3.3.2.2 Identification of small SDS-insoluble expanded polyglutamine protein 
species 
3.3.2.2. J Accumulation of SDS-insoluble expanded polyglutamine protein 
positively correlates with progressive neuronal degeneration 
Expanded polyQ protein shows a tendency to accumulate in SDS-insoluble 
form (section 3.1.2.1.3); a temporal accumulation of SDS-insoluble MJDtrQ78 
protein was detected in the stacking gel portion from 4 to 12 dpi (Figure 9; Figure 
25A). To confirm this, FA extraction of SDS-insoluble polyQ protein (Hazeki et al., 
2000; Hoffner et al., 2005; luchi et al., 2003) in MJDtrQ78-expressing flies was 
performed. 100% FA dissolves most SDS-insoluble MJDtrQ78 proteins in flies 
(Figure 24; Lam and Chan, unpublished data). Using this method, a temporal 
accumulation of SDS-insoluble (FA-extractable) MJDtrQ78 protein was again 
observed from 4 to 12 dpi (Figure 25B). These results demonstrate a concomitant 
buildup of SDS-insoluble expanded polyQ protein (Figure 9; Figure 25) with 
neuronal degeneration (Figure 12). 
丄 Accumulation of large SDS-insoluble expanded polyglutamine protein 
does not correlate with neuronal degeneration 
Filter retardation assay (Wanker et al., 1999) was employed as an alternative 
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Figure 24. Formic acid dissolves SDS-insoluble 
MJDtrQ78 protein. Formic acid treatment of the SDS-
insoluble MJDtrQ78 protein extract of adult flies. 
Without formic acid treatment, SDS-insoluble 
MJDtrQ78 protein was detected in the stacking gel 
portion (indicated by bar) using Western blot analysis. 
The MJDtrQ78 protein was found in the running gel 
portion (indicated by arrows) upon treatment with 100 
percent (%) formic acid. The flies were of genotype w; 
gmr-GAL4 UAS-MJDtrQ78(s)l+\ +/+. (Lam and Chan, 
unpublished data). 
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Figure 25. Temporal accumulation of SDS-insoluble MJDtrQ78 
protein. (A) Western blot analysis of the MJDtrQ78 protein extract of 
adult flies. An increase in the level of SDS-insoluble MJDtrQ78 protein 
was detected from 4 days post-induction (dpi) to 12 dpi (stacking gel; 
indicated by bar). /S -tubulin was used as the loading control (*p < 0.05; 
unpaired Student's t-test). (B) Detection of SDS-insoluble MJDtrQ78 
protein of adult flies after formic acid (100 percent) treatment. The level 
of SDS-insoluble formic acid-extractable MJDtrQ78 protein (of 
monomeric size of about 35 kDa; indicated by arrow) increased from 4 to 
12 dpi < 0.05; unpaired Student's t-test). High-molecular-weight 
MJDtrQ78 protein species (indicated by arrowheads) were detected at 12, 
but not 4 dpi. Error bars represent the mean 土 s.c.m. of three independent 
experiments. The flies were of genotype w; gmr-GAL4 UAS-
MJDtrQ78(s)/+; tubP-GAL80ts/+. 
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approach to study the temporal accumulation of polyQ protein; interestingly though, 
no significant buildup of SDS-insoluble MJDtrQ78 protein from 4 to 12 dpi was 
detected (Figure 26A). In filter retardation assay, only SDS-insoluble MJDtrQ78 
protein species with size larger than 0.22 i^m would be retained on the cellulose 
acetate membrane. This observation argues that the accumulation of "large" (> 0.22 
|im) SDS-insoluble MJDtrQ78 protein does not increase with neuronal degeneration 
as demonstrated in Figure 12. 
The involvement of large SDS-insoluble expanded polyQ protein in neuronal 
degeneration was further evaluated by manipulating its abundance in the inducible 
MJDtrQ78 model. The ATPase-defective form of Hsc70 (Hsc70-K71S; section 
3.2.2.1.1) reduced the level of microscopically visible MJDtrQ78 protein aggregates, 
and meanwhile there was a positive correlation between the accumulation of 
microscopically visible aggregates and large SDS-insoluble polyQ protein (Figure 
16). The effect of Hsc70-K71S on large SDS-insoluble MJDtrQ78 protein was 
therefore tested. In MJDtrQ78 flies co-expressed with Hsc70-K71S, the level of large 
SDS-insoluble MJDtrQ78 protein was reduced at both 4 and 12 dpi (Figure 26A). 
Meanwhile, using immunoprecipitation, co-expression of Hsc70-K71S did not alter 
the level of SDS-soluble MJDtrQ78 protein (Figure 26B). These results demonstrate 
























































































































































































































































































































































































































































































































































































































































































































































































































that Hsc70-K71S selectively acts on large SDS-insoluble expanded polyQ protein 
species. As Hsc70-K71S co-expression exerted neither suppression nor enhancement 
of MJDtrQ78-induced neuronal degeneration (Figure 19), this further indicates that 
the level of large SDS-insoluble expanded polyQ protein does not associate with 
neuronal degeneration. 
3.3.2.2.3 Accumulation of small SDS-insoluble expanded polyglutamine protein 
correlates with neuronal degeneration 
A temporal accretion of SDS-insoluble MJDtrQ78 protein was observed in this 
inducible model from 4 to 12 dpi (Figure 9; Figure 25). Conversely, the level of 
SDS-insoluble MJDtrQ78 protein retained on the filter membrane did not appear to 
accumulate within the same period of time (Figure 26A). This therefore favors an 
idea that there was a temporal accumulation (from 4 to 12 dpi) of MJDtrQ78 protein 
species that are SDS-insoluble and of size less than 0.22 \xm. 
To show the presence of such "small" (< 0.22 |im) SDS-insoluble MJDtrQ78 
protein species, MJDtrQ78-expressing fly protein extracts were filtered through a 
membrane with pore size of 0.22 |im. Using filter retardation assay, no detectable 
amount of SDS-insoluble MJDtrQ78 protein was found after filtration (Figure 27A). 





























































































































































































































































































































































































































































































































































































































































































































































































This indicates that the filtration process effectively removes large SDS-insoluble 
MJDtrQ78 protein. Notably, after filtration, an increased amount of SDS-insoluble 
polyQ protein was detected at the stacking gel portion in MJDtrQ78-expressing flies 
from 4 to 12 dpi (Figure 27B). Together with the data showing that neuronal 
degeneration occurred at 12 dpi but not 4 dpi (Figure 12), a contemporaneous 
accumulation of small SDS-insoluble polyQ protein species (Figure 27B) and 
neuronal degeneration (Figure 12) was therefore clearly demonstrated. 
To further examine the link between small SDS-insoluble expanded polyQ 
protein species and neuronal degeneration, the level of small SDS-insoluble 
MJDtrQ?8 protein was monitored in MJDtrQ78 flies co-expressed with Hsc70-K71S. 
Co-expression of Hsc70-K71S was shown to have no effect on MJDtrQ78-induced 
degeneration (Figure 19). At the time when degeneration occurred (i.e. 12 dpi; Figure 
19)，the accumulation of small SDS-insoluble MJDtrQ78 protein was observed in the 
stacking gel portion in MJDtrQ78/Hsc70-K71 S-expressing flies, as in 
MJDtrQ78-expressing flies (Figure 210). These results therefore demonstrate the 
association between small SDS-insoluble MJDtrQ78 protein species and neuronal 
degeneration. Altogether, these findings indicate that small SDS-insoluble expanded 
polyQ protein species exerts a neurotoxic role. 
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3.3.3 Discussion 
Several types of expanded polyQ protein species were identified in this inducible 
Drosophila model, and they include monomeric SDS-soluble (Figure 9), "large" 
SDS-insoluble (Figure 10; Figure 26A) and "small" SDS-insoluble (Figure 27) 
expanded polyQ protein species. Contribution of these expanded polyQ protein 
species to neuronal degeneration was assessed in this inducible model. Temporal 
analyses demonstrated that MJDtrQ78-induced neuronal degeneration (Figure 12) 
was tied with the accumulation of small SDS-insoluble (Figure 27B), but not 
monomeric SDS-soluble (Figure 9) and large SDS-insoluble (Figure 26A), expanded 
polyQ protein species. At the time when degeneration occurred, the level of small 
(Figure 27C), but not large (Figure 26A), SDS-insoluble MJDtrQ78 protein species 
remained unaffected by action of Hsc70-K71S, which also did not either modulate 
neuronal degeneration (Figure 19). Despite the mechanism governing the selective 
action of Hsc70-K71S on distinct type of the expanded polyQ protein being currently 
unknown, these results altogether provide evidence that small SDS-insoluble 
expanded polyQ protein species is associated with neuronal degeneration. 
High-molecular-weight SDS-soluble expanded polyQ protein species have been 
detected in yeast models of HD (Behrends et al” 2006; Schaffar et al., 2004) and a 
1 0 7 ' 
transgenic mouse model of SBMA (Li et al., 2006), and that which were shown to 
associate with degenerative phenotypes. Similar protein species were not detected in 
this inducible transgenic fly model of MJD, which may be due to the difference in 
expression levels of the polyQ protein and/or the disease protein used between these 
investigations. Summing up the data from this inducible fly model, the i n v o l v e m e n t 
of small SDS-insoluble expanded polyQ protein species in neuronal degeneration is 
strongly suggested. 
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3.4 Biophysical characterization of small SDS-insoluble expanded 
polyglutamine protein species 
3.4.1 Introduction 
Expanded polyQ disease proteins exist in a number of biophysical 
conformations (section 1.4) that exhibit distinct biochemical solubility properties. 
For instance, expanded polyQ protein monomers of native or p-sheet conformation 
(Nagai et al., 2007) and amorphous aggregates (Muchowski et al., 2000) were found 
to be SDS soluble, whereas spherical oligomers (Wacker et al” 2004), annular 
oligomers (Wacker et al., 2004) and fibrils (Muchowski et al., 2000; Poirier et al., 
2002) were demonstrated to be SDS insoluble. In the previous section 3.3， 
biochemical and filtration analyses identified small SDS-insoluble expanded polyQ 
protein as a strong candidate to be a neurotoxic species in polyQ pathogenesis. 
However, it is not known if such protein species comprise a distinct type of polyQ 
protein conformers. To address this issue, sucrose gradient sedimentation and atomic 
force microscopy (AFM) were employed as parallel approaches to characterize the 
biophysical properties of such toxic species. 
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3.4.2 Results 
3.4.2.1 Separation of expanded polyglutamine protein species by sucrose 
gradient sedimentation 
Protein conformers can be separated by means of sucrose gradient 
sedimentation based on their sedimentation coefficients (Dehay and Bertolotti, 2006; 
Schrodel and de Marco, 2005). In previous cell culture studies, expanded polyQ 
proteins were found to sediment broadly across fractions of different sucrose 
densities (Chai et al., 2001; Dehay and Bertolotti, 2006), and the expanded polyQ 
proteins of different conformations sedimented at dissimilar rates in a sucrose 
gradient (Dehay and Bertolotti, 2006). These observations concur with the idea that 
the expanded polyQ protein exhibits different conformations in the cell. Here, 
sucrose gradient sedimentation was performed to review the sedimentation profile of 
MJDtrQ78 protein in Drosophila. In brief, a continuous sucrose density gradient 
(10% to 50%) was generated, and protein extracts from MJDtrQ78-expressing flies 
were centrifuged through the gradient. After the separation, 11 fractions (each of 1 
ml) were collected and subject to Western blot analysis. As expected, SDS-soluble 
MJDtrQ78 protein was isolated only from fraction of low sucrose density (i.e. 
fraction 2) while SDS-insoluble MJDtrQ78 protein was sedimented across a broad 
range of fractions of high sucrose density (i.e. fractions 7 to 10; Figure 28). This 





fraction 1 2 3 4 5 6 7 8 9 10 11 
•
l u 
Figure 28. Sucrose gradient sedimentation analysis on 
MJDtrQ78 protein. Separation of the MJDtrQ78 protein using a 
continuous 10 to 50 percent sucrose density gradient. At 12 days 
of post-induction (dpi) of MJDtrQ78 expression, SDS-soluble 
monomeric MJDtrQ78 protein (of about 35 kDa; indicated by 
arrow) was detected at fraction 2. SDS-insoluble MJDtrQ78 
protein sedimented broadly across fractions 7 to 10 in the 
stacking gel portion (indicated by bar). Similar results were 
observed in three independent experiments. The flies were of 
g e n o t y p e w; gmr-GAL4 UAS-MJDtrQ78(s)tubP-
GAL80tsl+, 
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result therefore indicates that the expanded MJDtrQ78 protein exists in different 
conformations in vivo. 
To check whether the small SDS-insoluble MJDtrQ78 protein fraction 
comprises a particular type of protein conformers with distinct sedimentation 
coefficient, the 11 protein fractions collected from sucrose gradient sedimentation 
analysis were filtered through an 0.22-|im membrane before Western blot analysis. In 
one experiment, small SDS-insoluble MJDtrQ78 protein species was identified in 
several sucrose density fractions collected. However, such species were not 
reproducibly detected in three other independent sucrose gradient sedimentation 
experiments performed. The result was therefore inconclusive. 
3.4.2.2 Morphological studies of small SDS-insoluble expanded polyglutamine 
protein species by atomic force microscopy 
Atomic force microscopy (AFM) has been commonly used to investigate the 
morphology of proteins (reviewed by Engel and Muller, 2000; Lyubchenko et al., 
2006), including the polyQ protein (Dahlgren et al., 2005; Diaz-Hernandez et al., 
2004; Ehmhoefer et al., 2006; Li et al., 2006; Mukai et al., 2005; Poirier et al., 2002; 
Wacker et al., 2004). The possibility to utilize AFM to study the morphological 
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appearance of the small SDS-insoluble polyQ protein species was explored. 
SDS-insoluble MJDtrQ78 protein was isolated by immunoprecipitation (Figure 29), 
filtered through membrane with pore size of 0.22 |im, and visualized directly under 
AFM. A population of round-shaped particles was detected at 12 dpi of MJDtrQ78 
expression, but not at 0 dpi which serves as the negative control (Figure 3OA). These 
round-shaped particles were estimated to have their size (height) ranging from 5 to 
60 nm (Figure 30B), and over 90 percent of them were within the size (height) range 
of 5 to 20 nm (i.e. 964 out of 1022 round-shaped particles; Figure 30B). Meanwhile, 
the overall density (particles/field) of these round-shaped particles (i.e. 5 to 20 nm) 
significantly increased from 4 to 12 dpi (Figure 30B), which is in line with the 
temporal accumulation of small SDS-insoluble MJDtrQ78 protein species observed 
in the biochemical and filtration analyses (Figure 27). These results collectively 
indicate that small SDS-insoluble MJDtrQ78 protein species encompasses a 
population of round-shaped particles. 
Ordered arrays of round-shaped particles (Figure 3OA) and fibril-like structures 
(Figure 31) were also observed in the sample of small SDS-insoluble MJDtrQ78 
protein species. These structures were of length varied from 45 to 275 nm, and height 
ranging from 5 to 10 nm (Figure 31). Meanwhile, no remarkable change in the 
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Figure 29. Immunoprecipitation of SDS-insoluble 
M J D t r Q 7 8 prote in . Western blot analys is of 
immunoprecipitated MJDtrQ78 protein of adult flies. SDS-
soluble monomeric MJDtrQ78 protein (of about 35 kDa; 
indicated by arrow) was detected in the eluent (Elu) fraction 
at 4, but not 12 days post-induction (dpi). SDS-insoluble 
MJDtrQ78 protein was detected in the stacking gel portion 
(indicated by bar) of the Elu fraction at both 4 and 12 dpi. 
No MJDtrQ78 protein was found in the flowthrough (FT) 
fraction. Similar results were observed in three independent 
experiments. The flies were of genotype w; gmr-GAL4 
UAS-MJDtrQ78(s)/+\ tubP-GAL80ts/+. 
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Figure 31. Detection of MJDtrQ78 protofibrils. Atomic 
force microscopy (AFM) image of the immunoprecipitated 
small SDS-insoluble MJDtrQ78 protein. Apart from 
spherical particles (indicated by arrows), fibrillar structures 
(indicated by arrowhead) were occasionally detected. Scale 
bars represent 100 nm. Height scan across of a fibrillar 
structure (i.e. at 12 days post-induction (dpi); indicated by 
line) showed its height (Z-scale) to be about 5 nm, and its 
length (X-scale) to be approximately 150 nm. The flies 




overall height was detected along these structures (Figure 31). These structures 
however contributed only to less than 4 percent of the detected population of 
particles (i.e. 41 out of 1063 particles). With such small quantity, their overall density 
(particles/field) was not compared among different time points. 
3.4.3 Discussion 
After sucrose gradient sedimentation, SDS-soluble and SDS-insoluble 
MJDtrQ78 proteins were sedimented in separated fractions (Figure 28), this 
demonstrates their inimitable sedimentation coefficients. Higher sedimentation 
coefficient of SDS-insoluble than SDS-soluble MJDtrQ78 protein is indicative of the 
presence of a macromolecular conformer and/or an adoption of a dense misfolded 
conformation (Chai et al., 2001; Dehay and Bertolotti, 2006). Likewise, small 
SDS-insoluble MJDtrQ78 protein species perhaps exists in a conformation of 
sedimentation coefficient distinct from large SDS-insoluble protein species. 
Unfortunately, small SDS-insoluble MJDtrQ78 protein was not reproducibly detected 
in sucrose gradient sedimentation experiments, which may be due to the considerable 
protein loss after numerous steps of isolation and extraction procedures. 
Expanded polyQ protein exists in several biophysical conformations such as 
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spherical oligomers, annular oligomers, amorphous aggregates, protofibrils and 
fibrils (section 1.4). These polyQ conformers were reported to have dissimilar 
morphological appearance (Table 3; Figure 32) under AFM analysis. One limitation 
of AFM is, however, on the size determination of a particle. The diameter of a 
particle imaged is often perturbed by the size of the AFM tip, which is referred to as 
AFM tip convolution (Bustamante and Keller, 1995). The error would be more 
significant when a small particle size is measured. Despite the additional height 
errors introduced by tip compression and surface adsorption forces, the height value, 
rather than the diameter, is a more accurate measure of the particle size. With AFM， 
the particle size is often therefore defined as the maximum height of the particle. Size 
ranges reported for various polyQ conformers under AFM were summarized in Table 
3 for references. 
To characterize the biophysical conformation of small SDS-insoluble expanded 
polyQ protein species identified in this inducible fly model (section 3.3)， 
SDS-insoluble MJDtrQ?8 protein was isolated by immunoprecipitation (Figure 29), 
filtered through a membrane with pore size of 0.22 fim, and subject to AFM analysis. 
The predominant structures observed were particles that are round-shaped (Figure 
30A) and have a size range of 5 to 60 nm (Figure 30B). The morphology and size of 









































































































































































































































































































































































































































































































































































Figure 32. Morphological appearance of expanded polyQ 
protein conformers under atomic force microscopy. Atomic 
force microscopy (AFM) images of expanded polyQ protein 
conformers, which include spherical oligomers, annular 
oligomers, protofibrils, fibrils, and amorphous aggregates. The 
polyQ conformer was highlighted by arrow(s) and with scale bar 
specified in each image. (Modified from Wacker et al. (2004) 
and Li et al. (2006)). 
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these particles resembled those described previously for spherical polyQ oligomers 
(Table 3; Figure 32; Ehrnhoefer et al., 2006; Mukai et al., 2005; Wacker et al., 2004). 
Small SDS-insoluble MJDtrQ78 protein species therefore existed mostly in form of 
spherical oligomers. Ordered arrays of round-shaped particles (Figure 30A) and 
fibril-like structures (Figure 31) were also occasionally observed in the sample of 
small SDS-insoluble MJDtrQ78 protein species. These structures had morphological 
feature and size similar to those reported for protofibrils (Table 3; Figure 32; 
Diaz-Hernandez et al., 2004; Li et al., 2006; Poirier et al., 2002). A minor portion of 
small SDS-insoluble MJDtrQ78 protein species thus existed in form of protofibrils. 
In AFM studies on the polyQ protein, protofibrils were shown to comprise units of 
spherical oligomers (Diaz-Hemandez et al., 2004; Li et al., 2006; Poirier et al., 2002), 
which indicates that protofibrils are indeed assemblies of spherical oligomers. Taken 
together, results indicate that small SDS-insoluble MJDtrQ78 protein species exist 
principally in form of spherical oligomers. 
Neuronal degeneration occurred with a temporal accumulation of small 
SDS-insoluble MJDtrQ78 protein species (i.e. from 4 to 12 dpi; section 3.3). 
Concomitantly, a significant buildup of spherical MJDtrQ78 protein oligomers (of 
size ranging from 5-20 nm; encompass over 90 percent of total small SDS-insoluble 
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MJDtrQ78 protein species) was detected (Figure 308). These results therefore 
suggest the neurotoxic property of such spherical polyQ oligomers. 
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4. GENERAL DISCUSSION 
Aggregation of disease protein is a common trait of various neurodegenerative 
disorders (section 1.1) including polyQ diseases (section 1.2). For over a decade, the 
mechanism and role of protein aggregation are topical areas of research (section 1.3; 
section 1.4). Disease-causing proteins are known to exist in a number of aggregated 
forms with distinct biophysical conformation (section 1.4) and biochemical solubility 
properties (section 3.4.1). A major challenge has been to identify the distinct form of 
disease protein species which is decisive for pathogenesis (reviewed by Caughey and 
Lansbury, 2003). 
The relationship between protein aggregates and neurodegeneration cannot be 
however readily assessed in human beings due to ethical issues and also the naturally 
long pre-symptomatic period (section 1.1). Clinically characterized tissues are likely 
to represent only the advanced stage of the disease progression. To compare the 
course of protein aggregation and neurodegeneration, researchers have shifted to 
animal modeling studies (reviewed by Caughey and Lansbury, 2003; Zoghbi and Orr, 
2000). Nowadays, Drosophila emerges as one of the most employed models to 
examine pathogenic mechanisms in neurodegenerative disorders such as polyQ 
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diseases (section 1.5). 
In this work, an inducible fly model was established to look into the link 
between polyQ protein aggregates and neurodegeneration and, with an ultimate goal, 
to uncover the identity of the toxic polyQ protein species (section 3.1). This 
inducible model recapitulates early pathogenic features of polyQ diseases, including 
neuronal degeneration without cell death (section 3.1.2.2.1; section 3.1.2.2.2), and 
formation of protein aggregates (section 3.1.2.1.4). This model would hence facilitate 
the investigation on polyQ protein aggregation during the early stage of neuronal 
degeneration. 
To look for distinct polyQ protein species that are toxic in nature, a prerequisite 
criterion to be considered would be its association with neuronal degeneration. In this 
inducible fly model, microscopically visible polyQ aggregates appear to exert neither 
a neurotoxic nor protective role in triggering poIyQ-mediated neuronal degeneration 
(section 3.2.2.1). Further, cellular load of these polyQ aggregates also does not have 
a direct implication in neuronal degeneration (section 3.2.2.2.). Expanded polyQ 
protein species that appear diffuse, rather than distinct, under light microscopy may 
indeed be toxic (Arrasate et al., 2004; Taylor et al., 2003a); however, it is not known 
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in which form(s) of this small diffuse disease protein species would trigger 
detrimental effects in the cell. Notably, my biochemical and filtration analyses 
identified a toxic, small-sized, SDS-insoluble expanded polyQ protein species 
(section 3.3), and such polyQ protein species was further demonstrated to be in form 
of spherical oligomers (section 3.4.2.2; section 3.4.3). These results provide evidence 
that spherical polyQ oligomers exist in vivo and underlie neuronal degeneration. 
In this study, the involvement of polyQ disease protein species in the early stage 
of neuronal degeneration was evaluated. The contributions of other polyQ species to 
long-term neurotoxicity, for example when cell death occurs, were not inevitably 
ruled out. Remarkably though, the identification of spherical oligomers as pathogenic 
polyQ protein species is in line with the detection of toxic oligomers described in 
other neurodegenerative disorders (reviewed by Caughey and Lansbury, 2003) 
including amyloid p oligomers in Alzheimer's disease (Walsh et al., 2002) and 
a-synuclein spherical oligomers in Parkinson's disease (Conway et al., 1998). This 
highlights that various neurodegenerative disorders may share a common pathogenic 
mechanism. 
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5. CONCLUSION 
This project aims to address two important questions in polyQ pathogenesis, 
which are 1) the role of protein aggregates in neurodegeneration, and 2) the toxic 
form of polyQ protein species. An inducible Drosophila model was established to 
monitor both polyQ disease protein aggregation and neuronal degeneration in vivo. 
Progressive degeneration of neurons was observed in this model; results further 
indicate that the early stage of degeneration involve mechanisms such as alteration of 
endogenous Hsp70 molecular chaperone protein level. Accumulation of 
microscopically visible protein aggregates is a hallmark feature of polyQ diseases; 
such accretion was also detected in the inducible model. However, these aggregates 
did not exert a protective or detrimental role in neuronal degeneration. Indeed, a 
biochemically-characterized form of small-sized SDS-insoluble polyQ protein 
species was associated tightly with neuronal degeneration. Such neurotoxic polyQ 
species was further demonstrated to exist in a conformation of spherical oligomers. 
The present study directly demonstrates that spherical polyQ oligomers are involved 
in neuronal degeneration in vivo. 
To learn how these spherical polyQ oligomers underlie neuronal degeneration, a 
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few more issues are to be addressed. For example, to find out the mechanism by 
which these polyQ oligomers formed, to uncover the composition of these polyQ 
oligomers, and to identify cellular interacting partners of these polyQ oligomers. 
Learning all these would give a better understanding of the involvement of spherical 
polyQ oligomers in neurodegeneration. 
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